+

US20080145867A1 - Genes encoding a novel type of lysophophatidylcholine acyltransferases and their use to increase triacylglycerol production and/or modify fatty acid composition - Google Patents

Genes encoding a novel type of lysophophatidylcholine acyltransferases and their use to increase triacylglycerol production and/or modify fatty acid composition Download PDF

Info

Publication number
US20080145867A1
US20080145867A1 US11/820,014 US82001407A US2008145867A1 US 20080145867 A1 US20080145867 A1 US 20080145867A1 US 82001407 A US82001407 A US 82001407A US 2008145867 A1 US2008145867 A1 US 2008145867A1
Authority
US
United States
Prior art keywords
seq
lpcat
plant
nucleic acid
yeast
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
US11/820,014
Other versions
US7732155B2 (en
Inventor
Jitao Zou
Qilin CHEN
Zhifu Zheng
Jingyu Xu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
National Research Council of Canada
Corteva Agriscience LLC
Original Assignee
National Research Council of Canada
Dow AgroSciences LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US11/820,014 priority Critical patent/US7732155B2/en
Application filed by National Research Council of Canada, Dow AgroSciences LLC filed Critical National Research Council of Canada
Priority to CA2862907A priority patent/CA2862907C/en
Priority to AU2007334364A priority patent/AU2007334364B2/en
Priority to CA2671674A priority patent/CA2671674C/en
Priority to PCT/US2007/025650 priority patent/WO2008076377A2/en
Priority to US12/448,061 priority patent/US8383886B2/en
Publication of US20080145867A1 publication Critical patent/US20080145867A1/en
Assigned to NATIONAL RESEARCH COUNCIL OF CANADA reassignment NATIONAL RESEARCH COUNCIL OF CANADA ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: ZOU, JITAO, CHEN, QILIN, XU, JINGYU
Assigned to DOW AGROSCIENCES LCC reassignment DOW AGROSCIENCES LCC ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: ZHENG, ZHIFU
Application granted granted Critical
Publication of US7732155B2 publication Critical patent/US7732155B2/en
Priority to US13/745,257 priority patent/US9228175B2/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/1025Acyltransferases (2.3)
    • C12N9/1029Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase

Definitions

  • the invention relates generally to biotechnology, and, more particularly, to lyso-phosphatidylcholine (LPC) acyltransferase, polynucleotides that encode LPC acyltransferases, and associated methods.
  • LPC lyso-phosphatidylcholine
  • PC Phosphatidylcholine
  • DAG diacylglycerol
  • LPCAT LPC acyltransferases
  • LPCAT enzymes catalyze the acylation of LPC molecules to form PC and play a pivotal role in membrane biogenesis. They can also exert a reversible reaction to release the fatty acyl chain esterified to the sn-2 position of PC, thereby contributing to a continuous remodeling of fatty acyl-CoA and PC pools.
  • LPCAT glycerolipid metabolism of eukaryotic systems
  • PUFA very long chain polyunsaturated fatty acid
  • this enzyme is believed to represent a bottleneck for acyl exchange between the fatty acyl elongation and de-saturation systems.
  • the function of this enzyme is largely unknown, but it has been proposed that the enzyme is involved in the selective incorporation of fatty acids into storage pool.
  • LPCAT Previously reported LPCAT share a substantial sequence homology to glycerol-3-phosphate acyltransferase and lysophosphatidic acyltransferase.
  • the LPCAT sequences disclosed herein are unrelated to any known LPCAT sequences, and belong to a new class of LPCAT.
  • Four conserved motifs were identified in this novel class of LPCAT enzymes. The identified motifs are different from previously reported LPCAT, which contain motifs having a high degree of similarity to those in other known acyltransferases employing glycerol-3-phosphate and lysophosphatidic acid as substrates.
  • sequence information of the motifs identified herein is novel, and can lead to the identification of new class of LPCAT genes from a broad spectrum of species.
  • a lyso-phosphatidylcholine acyltransferase gene or class of genes is identified.
  • the LPC acyltransferase gene may be expressed or overexpressed in a cell and used to modify glycerolipid biosynthesis in a cell.
  • Such an LPC acyltransferase gene may be expressed or overexpressed in a cell and used to modulate or enhance production of fatty acids, especially polyunsaturated fatty acids (PUFA) or other unusual fatty acids, and/or to increased oil content in the cell.
  • the LPC acyltransferase gene may be expressed or overexpressed in planta in order to modify glycerolipid biosynthesis in a plant.
  • the LPC acyltransferase gene is expressed or overexpressed in planta in order to enhance the production of fatty acids in a plant.
  • a plant, plant seed or progeny thereof includes a recombinant cell having an LPC acyltransferase gene.
  • a vector having an LPC acyltransferase gene.
  • the vector may be used to transform a cell, thus producing a recombinant cell having the LPC acyltransferase gene.
  • the cell may comprise, for example, a bacterial cell, a yeast cell, or a plant cell.
  • a recombinant cell expresses an LPC acyltransferase gene and produces an LPC acyltransferase polypeptide that may be isolated or purified from the cell.
  • nucleotide and deduced amino acid sequences associated with an LPC acyltransferase gene are disclosed.
  • the sequence, or a portion thereof, may be used to identify genes from other species that encode polypeptides with LPC acyltransferase activity.
  • a process for producing fatty acids includes transforming a cell with an LPC acyltransferase gene.
  • the transformed cell expresses the fatty acid acyltransferase gene and produces fatty acids.
  • the fatty acids may be isolated or purified from the recombinant cell or culture media in which the cell grows, and subsequently incorporated into a composition.
  • knock-out mutants disrupted in LPC acyltransferase gene of yeast and plants are identified.
  • a peptide comprising one or more of the four motifs may be used as an LPC Acyltransferase.
  • a nucleotide sequence encoding a peptide comprising one or more of the four motifs may be used as an LPC Acyltransferase.
  • an isolated or recombinant nucleic acid molecule encoding an LPC acyltransferase and a cell transformed with the isolated or recombinant nucleic acid molecule as described herein.
  • a process for increasing fatty acid production in a cell comprising: transforming a cell with a nucleic acid molecule encoding an LPC acyltransferase; and, growing the cell under conditions wherein said LPC acyltransferase is expressed.
  • a purified or an isolated LPC acyltransferase are also provided.
  • LPCAT enzymes play a critical role in remodeling fatty acid and PC pools as well as PC synthesis.
  • the remodeled fatty acyl chains in the form of acyl-CoA or esterified at the sn-2 position of PC can be used for triacylglycerol synthesis.
  • this novel type of LPCAT isolated from the organisms where very-long-chain polyunsaturated fatty acids (VLCPUFA) are present at a high level can be used to increase the production of VLCPUFA.
  • VLCPUFA very-long-chain polyunsaturated fatty acids
  • this novel type of LPCAT isolated from species containing high amount of unusual fatty acids can be used to increase the production of unusual fatty acids.
  • LPCAT enzymes isolated from castor bean are useful in increasing the production of hydroxyl fatty acids in oil seeds.
  • the enzyme activity described herein provides support that the motif-based gene searching is a useful approach.
  • FIG. 1 is a graph of LPCAT activity (nmol/mg ⁇ h) of wild type (WT) and YOC175c mutant yeast strains.
  • FIG. 2 is an alignment of LPCAT sequences from different species that revealing, among other things, four conserved motifs unique for this type of LPCAT enzymes.
  • FIG. 3 is another alignment of LPCAT sequences from different plant species that revealed four conserved motifs (SEQ ID NOS: 81-84).
  • FIG. 4 is depicts the expression of the TpLCAT in lpcat mutant was able to complement the sensitivity of the lpcat mutant to Lyso-PAF.
  • FIG. 5 is a graph showing the expression of TpLPCAT in yeast.
  • LPCAT assays were performed on cell lysates of yeast lpcat mutant strain By02431 transformed with TpLPCAT/pYES2.1 and pYes2.1/V5-His-TOPO plasmid only (control) in the presence of 14 C-Lyso-PC and different acyl-CoAs.
  • FIG. 6 comprises TLC plates of LPCAT assays on cell lysates of yeast lpcat mutant strain By02431 transformed with TpLPCAT/pYES2.1 and pYes2.1/V5-His-TOPO plasmid only (control) in the presence of 14 C-Lyso-PC and different acyl-CoAs. 1, 3, 5, 7, 9, 11, and 13-TpLPCAT; 2, 4, 6, 8, 10, 12, and 14-empty vector.
  • FIG. 7 shows a LysoPAF sensitivity test of YOR175c mutant, AtLPCATs transformant, wherein A is VO/BY02431, B is AtLPCAT1/BY02431, and C is AtLPCAT2/BY02431.
  • FIG. 8 is a graph showing the Lyso-lipid substrate specificity of Arabidopsis LPCATs.
  • the nucleic acid molecule encoding the LPC acyltransferase is derived from yeast, plant and mammal species.
  • Yeast species include, for example, species of the genus Saccharomyces, for example Saccharomyces cerevisiae.
  • Plant species include, for example, species of the family Brassicaceae. Of the family Brassicaceae, species of genus Brassica and genus Arabidopsis are of particular note, for example Arabidopsis thaliana .
  • Mammalian species include mouse and human.
  • nucleic acid molecule encoding an LPC acyltransferase from S. cerevisiae and two nucleic acid molecules encoding two different isoforms of LPC acyltransferase from A. thaliana .
  • LPC acyltransferases encoded by the aforementioned nucleic acid molecules.
  • nucleic acid molecule having a nucleotide sequence encoding an LPC acyltransferase such as amino acid sequence comprising SEQ ID NO: 2, SEQ ID NO: 4, SEQ ID NO: 6, SEQ ID NO: 8, SEQ ID NO:10, SEQ ID NO:11; SEQ ID NO:13, SEQ ID NO:15, SEQ ID NO:17; SEQ ID NO:19, SEQ ID NO:21, SEQ ID NO:25, SEQ ID NO:27, SEQ ID NO:29, SEQ ID NO:31, SEQ ID NO:33, and SEQ ID NO:35.
  • LPC acyltransferase such as amino acid sequence comprising SEQ ID NO: 2, SEQ ID NO: 4, SEQ ID NO: 6, SEQ ID NO: 8, SEQ ID NO:10, SEQ ID NO:11; SEQ ID NO:13, SEQ ID NO:15, SEQ ID NO:17; SEQ ID NO:19, SEQ ID NO:21, SEQ ID NO:25, SEQ ID
  • an isolated or recombinant nucleic acid molecule having a nucleotide sequence comprising SEQ ID NO: 1, SEQ ID NO: 3, SEQ ID NO: 5, SEQ ID NO: 7, SEQ ID NO:9, SEQ ID NO:12, SEQ ID NO:14, SEQ ID NO:16, SEQ ID NO:18, SEQ ID NO:20, SEQ ID NO:24, SEQ ID NO:26, SEQ ID NO:28, SEQ ID NO:30, SEQ ID NO:32, or SEQ ID NO:34.
  • the LPC acyltransferase encoded by a nucleic acid molecule comprises an amino acid sequence comprises an amino acid sequence having at least 60% homology to the aforementioned sequences. Homology is more preferably at least 70%, 80%, 90%, or 95%. It will be appreciated that this disclosure embraces the degeneracy of codon usage as would be understood by one of ordinary skill in the art.
  • Homologs of the LPC acyltransferase genes described herein obtained from other organisms, for example plants may be obtained by screening appropriate libraries that include the homologs, wherein the screening is performed with the nucleotide sequence of the specific LPC acyltransferase genes of the instant invention or portions or probes thereof, or identified by sequence homology search using sequence alignment search programs such as BLAST, FASTA.
  • Hybridization conditions may be stringent in that hybridization will occur if there is at least a 90%, 95% or 97% identity with the nucleic acid molecule that encodes the LPC acyltransferase of the instant invention.
  • the stringent conditions may include those used for known Southern hybridizations such as, for example, incubation overnight at 42° C.
  • Nucleic acid molecules that code for an LPC acyltransferase may be transformed into an organism, for example a plant.
  • an organism for example a plant.
  • genes and gene constructs can be introduced into organisms, for example plants, and a combination of transformation and tissue culture techniques have been successfully integrated into effective strategies for creating transgenic organisms, for example crop plants. These methods, which can be used in the invention, have been described elsewhere (Potrykus, 1991; Vasil, 1994; Walden and Wingender, 1995; Songstad et al., 1995), and are well known to persons skilled in the art.
  • Agrobacterium Ti-plasmid-mediated transformation e.g., hypocotyl (DeBlock et al., 1989) or cotyledonary petiole (Moloney et al., 1989) wound infection
  • particle bombardment/biolistic methods Sanford et al., 1987; Nehra. et al., 1994; Becker et al., 1994
  • polyethylene glycol-assisted, protoplast transformation Rhodes et al., 1988; Shimamoto et al., 1989
  • plant promoters to direct any intended up- or down-regulation of transgene expression using constitutive promoters (e.g., those based on CaMV35S), or by using promoters which can target gene expression to particular cells, tissues (e.g., napin promoter for expression of transgenes in developing seed cotyledons), organs (e.g., roots), to a particular developmental stage, or in response to a particular external stimulus (e.g., heat shock).
  • constitutive promoters e.g., those based on CaMV35S
  • Promoters for use herein may be inducible, constitutive, or tissue-specific or have various combinations of such characteristics.
  • Useftil promoters include, but are not limited to constitutive promoters such as carnation etched ring virus (CERV), cauliflower mosaic virus (CaMV) 35S promoter, or more particularly the double enhanced cauliflower mosaic virus promoter, comprising two CaMV 35S promoters in tandem (referred to as a “Double 35S”promoter).
  • tissue-specific or developmentally regulated promoter may be desirable to use a tissue-specific or developmentally regulated promoter instead of a constitutive promoter in certain circumstances.
  • a tissue-specific promoter allows for overexpression in certain tissues without affecting expression in other tissues.
  • a preferred promoter used in overexpression of enzymes in seed tissue is an ACP promoter as described in PCT International Publication WO 92/18634, published Oct. 29, 1992, the disclosure of which is herein incorporated by reference.
  • the promoter and termination regulatory regions will be functional in the host plant cell and may be heterologous (that is, not naturally occurring) or homologous (derived from the plant host species) to the plant cell and the gene. Suitable promoters which may be used are described above.
  • the termination regulatory region may be derived from the 3′ region of the gene from which the promoter was obtained or from another gene. Suitable termination regions which may be used are well known in the art and include Agrobacterium tumefaciens nopaline synthase terminator (Tnos), A. tumefaciens mannopine synthase terminator (Tmas) and the CaMV 35S terminator (T35S). Particularly preferred termination regions for use herein include the pea ribulose bisphosphate carboxylase small subunit termination region (TrbcS) or the Tnos termination region. Such gene constructs may suitably be screened for activity by transformation into a host plant via Agrobacterium and screening for increased isoprenoid levels.
  • Tnos Agrobacterium tumefaciens nopaline synthase terminator
  • Tmas A. tumefaciens mannopine synthase terminator
  • T35S CaMV 35S terminator
  • the nucleotide sequences for the genes may be extracted from the GenBank® (a registered trademark of the U.S. Department of Health and Human Services) nucleotide database and searched for restriction enzymes that do not cut. These restriction sites may be added to the genes by conventional methods such as incorporating these sites in PCR primers or by sub-cloning.
  • a DNA construct for use herein is comprised within a vector, most suitably an expression vector adapted for expression in an appropriate host (plant) cell. It will be appreciated that any vector which is capable of producing a plant comprising the introduced DNA sequence will be sufficient.
  • Suitable vectors are well known to those skilled in the art and are described in general technical references such as Pouwels et al., Cloning Vectors. A Laboratory Manual, Elsevier, Amsterdam (1986). Particularly suitable vectors include the Ti plasmid vectors.
  • Transformation techniques for introducing the DNA constructs into host cells are well known in the art and include such methods as micro-injection, using polyethylene glycol, electroporation, or high velocity ballistic penetration.
  • a preferred method relies on Agrobacterium -mediated transformation. After transformation of the plant cells or plant, those plant cells or plants into which the desired DNA has been incorporated may be selected by such methods as antibiotic resistance, herbicide resistance, tolerance to amino-acid analogues or using phenotypic markers.
  • RNA samples may be used to determine whether the plant cell shows an increase in gene expression, for example, Northern blotting or quantitative reverse transcriptase PCR (RT-PCR).
  • RT-PCR quantitative reverse transcriptase PCR
  • Whole transgenic plants may be regenerated from the transformed cell by conventional methods.
  • Such transgenic plants having improved isoprenoid levels may be propagated and self-pollinated to produce homozygous lines.
  • Such plants produce seeds containing the genes for the introduced trait and can be grown to produce plants that will produce the selected phenotype.
  • Plants that may be modified or used for fatty acid production according to the instant invention include, without limitation, borage ( Borago spp.), Canola, castor ( Ricinus communis ); cocoa bean ( Theobroma cacao ), corn ( Zea mays ), cotton ( Gossypium spp), Crambe spp., Cuphea spp., flax ( Linum spp.), Lesquerella and Limnanthes spp., Linola, nasturtium ( Tropaeolum spp.), Oeanothera spp., olive ( Olea spp.), palm ( .Elaeis spp.), peanut ( Arachis spp.), rapeseed, safflower ( Carthamus spp.), soybean ( Glycine and Soja spp.), sunflower ( Helianthus spp.), tobacco ( Nicotiana spp.), Vernonia spp., wheat ( Triticum
  • genomic or sequence libraries of each of these plants may be screened with the nucleotide or amino acid sequences described herein (e.g., for one or more of the hereinafter identified conserved motifs (SEQ ID NO:46 through SEQ ID NO:49) for other sequences that encode or are homologous to sequences associated with the LPC acyltransferase of the instant invention.
  • Plants transformed with a nucleotide sequence of the instant invention that codes for an LPC acyltransferase may be grown. Seeds of the transgenic plants are harvested and fatty acids of the seeds are extracted. The extracted fatty acids are used for subsequent incorporation into a composition, for example a pharmaceutical composition, a nutraceutical composition or a food composition.
  • a peptide comprising one or more of the four motifs may be used as an LPC Acyltransferase.
  • a nucleotide sequence encoding a peptide comprising one or more of the four motifs may be used as an LPC Acyltransferase.
  • other methods of enhancing or altering oil production may also be used with the plant to be transformed (e.g., incorporating, for expression in the plant, a nucleic acid sequence selected from the group consisting of a nucleic acid sequence encoding a peptide having, for example, Brassica pyruvate dehydrogenase kinase activity (see, e.g., U.S. Pat. No. 7,214,859 to Marilla et al. (May 8, 2007), U.S. Pat. No. 6,500,670 to Zou et al. (Decemer 2002), and U.S. Pat. No. 6,256,636 to Randall et al.
  • a nucleic acid sequence selected from the group consisting of a nucleic acid sequence encoding a peptide having, for example, Brassica pyruvate dehydrogenase kinase activity (see, e.g., U.S. Pat. No. 7,214,859 to Marilla e
  • a process for producing a genetically transformed plant seed comprises introducing the nucleic acid into the plant seed.
  • Also described is a vector comprising SEQ ID NO: 1, SEQ ID NO: 3, SEQ ID NO: 5, SEQ ID NO: 7, SEQ ID NO:9, SEQ ID NO:12, SEQ ID NO:14, SEQ ID NO:16, SEQ ID NO:18, SEQ ID NO:20, SEQ ID NO:24, SEQ ID NO:26, SEQ ID NO:28, SEQ ID NO:30, SEQ ID NO:32, and/or SEQ ID NO:34.
  • nucleic acid sequence encoding a polypeptide having lyso-phosphatidylcholine acyltransferase activity
  • nucleic acid sequence comprises SEQ ID NO: 1, SEQ ID NO: 3, SEQ ID NO: 5, SEQ ID NO: 7, SEQ ID NO:9, SEQ ID NO:12, SEQ ID NO: 14, SEQ ID NO:16, SEQ ID NO:18, SEQ ID NO:20, SEQ ID NO:24, SEQ ID NO:26, SEQ ID NO:28, SEQ ID NO:30, SEQ ID NO:32, or SEQ ID NO:34, or a fragment of SEQ ID NO: 1, SEQ ID NO: 3, SEQ ID NO: 5, SEQ ID NO: 7, SEQ ID NO:9, SEQ ID NO:12, SEQ ID NO:14, SEQ ID NO:16, SEQ ID NO:18, SEQ ID NO:20, SEQ ID NO:24, SEQ ID NO:26, SEQ ID NO:28,
  • a method for increasing fatty acid production in a cell comprising transforming a cell with a nucleic acid molecule encoding a lyso-phosphatidylcholine acyltransferase; and growing the cell under conditions wherein the lyso-phosphatidylcholine acyltransferase is expressed.
  • the method can further comprise isolating the fatty acid.
  • the lyso-phosphatidylcholine acyltransferase preferably comprises at least one motif selected from the group consisting of SEQ ID NO: 46, SEQ ID NO: 47, SEQ ID NO: 48, SEQ ID NO: 49, and any combination thereof.
  • Also described is a method of altering oil content in a plant comprising screening for a peptide encoded by a nucleotide sequence for at least one of four motifs selected from the group consisting of SEQ ID NO: 46, SEQ ID NO: 47, SEQ ID NO: 48, and SEQ ID NO: 49; selecting the peptide based upon the presence of at least one of the four motifs; and expressing the nucleotide sequence encoding the peptide in the plant to alter the oil content of the plant.
  • Also described is a method of changing the oil content of a plant or plant seed comprising introducing a nucleic acid construct comprising a nucleic acid sequence encoding a polypeptide selected from the group consisting of SEQ ID NO: 2, SEQ ID NO: 4, SEQ ID NO: 6, SEQ ID NO: 8, SEQ ID NO:10, SEQ ID NO:11; SEQ ID NO:13, SEQ ID NO:15, SEQ ID NO:17; SEQ ID NO:19, SEQ ID NO:21, SEQ ID NO:25, SEQ ID NO:27, SEQ ID NO:29, SEQ ID NO:31, SEQ ID NO:33, SEQ ID NO:35, and an amino acid sequence having at least 60% homology to any thereof having lyso-phosphatidylcholine acyltransferase activity into a plant transformation vector; transforming a genome of a plant or plant seed with the plant transformation vector; expressing the nucleic acid sequence; growing the plant or plant seed; and extracting the oil from the group consist
  • the methods can further comprise incorporating, for expression in the plant, a nucleic acid sequence selected from the group consisting of a nucleic acid sequence encoding a peptide having pyruvate dehydrogenase kinase activity, a nucleic acid sequence encoding a peptide having diacylglycerol acyltransferase activity, a nucleic acid sequence encoding a peptide having glycerol-3-phosphate dehydrogenase activity, and any combination thereof.
  • the methods preferably involve a plant of the group consisting of borage ( Borago spp.), Canola, castor ( Ricinus communis ); cocoa bean ( Theobroma cacao ), corn ( Zea mays ), cotton ( Gossypium spp), Crambe spp., Cuphea spp., flax ( Linum spp.), Lesquerella and Limnanthes spp., Linola, nasturtium ( Tropaeolum spp.), Oeanothera spp., olive ( Olea spp.), palm ( .Elaeis spp.), peanut ( Arachis spp.), rapeseed, safflower ( Carthamus spp.), soybean ( Glycine and Soja spp.), sunflower ( Helianthus spp.), tobacco ( Nicotiana spp.), Vernonia spp,, wheat ( Triticum spp.), barley ( Horde
  • Nucleotide sequences of nucleic acid molecules of the invention were identified through yeast genetic and functional screening.
  • Yeast S. cerevisiae LPC acyltransferase gene was identified based on enzyme assays of yeast mutant strains in which the gene, YOR175c, was knocked out. The enzyme activity was assessed using 14C-labeled acyl-CoA and lyso-phosphatidylcholine. The reaction product of the lyso-phosphatidylcholine and radio-labeled acyl-CoA was separated through TLC and measured through scintillation counting.
  • YOR175c encodes LPC acyltransferase. Details are given below for the In Vitro Assay protocol for LPCAT (lyso-phosphatidylcholine (LPC) acyltransferase) activity.
  • Yeast culture One colony each of wild-type (strain BY4741) and LPCAT mutants (YOR175c deletion strains Y12431, Y02431) are inoculated in 10 ml YPD media and grown overnight. After 24 hr, another 20 ml YPD media is added and growth is continued for another 24 hr.
  • Protein extraction Yeast cultures are spun at 2800 rpm at 4° C. for 20 min. The supernatant is discarded and the yeast pellet washed with 10 ml of ice cold IB buffer (80 mM HEPES, 320 mM sucrose, 5 mM EDTA pH8, 10 mM KCl, 2 mM DTT). The pellets are spun again and re-suspend in 500 ⁇ l of IB buffer. Yeast cells are divided and transferred into 2 tubes appropriate for a mini-bead beater. 0.5 mm cold glass beads are added to fill completely the tube. To break the yeast cell, three 60 s pulses of the mini-bead beater are used. The mixtures are spun again to remove unbroken cells and debris.
  • IB buffer 80 mM HEPES, 320 mM sucrose, 5 mM EDTA pH8, 10 mM KCl, 2 mM DTT.
  • the pellets are spun again and re-suspend in 500
  • Protein assay conditions A reaction is conducted using the recipe for fatty-CoA substrate specificity, as listed in Table 1.
  • reaction mixture is allowed to sit in a water bath at 30° C. and stirred at 100 rpm for 30 min.
  • the reaction is then terminated by adding 2 ml of CH 2 Cl 2 : Isopropanol (1:2).
  • the mixture is allowed to sit at room temperature for 15-30 min with occasional vortexing.
  • Phases are separated by adding 2 ml CH 2 Cl 2 followed by 2 ml IM KCl in H 3 PO 4 .
  • the lower layer is transferred to a clean tube and the upper aqueous phase is backwashed twice with CH 2 Cl 2 and centrifuged, saving the organic phase each time.
  • Organic phases are combined and dried under nitrogen.
  • Dried material is taken up in 200 ⁇ l CH 2 Cl 2 : MeOH (2:1) and protein is separated by thin layer chromatography (TLC) using silica G (250 ⁇ m) commercial plate. Plates are developed to within 2 cm of top in ethyl acetate:isooctane:acetic acid (45:15:10, V/V/V), then dried and scraped. The phosphatidyl choline region is counted in 4 ml Aquasol-2 by a scintillation counter.
  • the YOR175c gene from S. cerevisiae has been identified as encoding an LPC acyltransferase.
  • the coding sequence of this yeast LPC acyltransferase gene is SEQ ID NO: 1:
  • the deduced amino acid sequence of the yeast LPC acyltransferase encoded by the gene is SEQ ID NO: 2:
  • the nucleotide sequence of the yeast LPC acyltransferase gene was used to search for homologous sequences using computer programs designed to search for homologous sequences.
  • readily commercially available computer programs that may be used for such searches include without limitation, BLASTN, BLASTX and TBLASTX which may be used to search for nucleotide sequences, and BLASTP and TBLASTN which may be used to search for amino acid sequences.
  • BLASTN BLASTN
  • BLASTX and TBLASTX
  • BLASTP and TBLASTN which may be used to search for amino acid sequences.
  • Such computer programs are readily accessible at the web-site www.ncbi.nlm.nih.gov.
  • Two plant ( A. thaliana ) homologs were identified through sequence alignment searching using BLAST.
  • the two homologs are cDNA sequences that encode two different isoforms of LPC acyltransferase.
  • Nucleotide sequence of Arabidopsis LPC acyltransferase 1 cDNA is SEQ ID NO: 3:
  • the deduced amino acid sequence of Arabidopsis LPC acyltransferase 1 is SEQ ID NO: 4:
  • Nucleotide sequence of Arabidopsis LPC acyltransferase 2 cDNA is SEQ ID NO: 5:
  • the deduced amino acid sequence of Arabidopsis LPC acyltransferase 2 is SEQ ID NO: 6:
  • Transformation protocol is adapted from that described by Bechtold et al. ( 1993 ). Plants are grown in moist soil at a density of 10-12 plants per pot, in 4-inch square pots, and are covered with a nylon screen fixed in place with an elastic band. When the plants reach the stage at which bolts emerge, plants are watered, the bolts and some of the leaves are clipped, and the plants are infiltrated in Agrobacterium suspension as outlined below.
  • Agrobacterium transformed with the LPC acyltransferase gene of the instant invention is grown in a 25 mL suspension in LB medium containing kanamycin at a concentration of 50 ⁇ g/mL.
  • the Agrobacterium is cultured for two to three days. The day before infiltration, this “seed culture” is added to 400 mL of LB medium containing 50 ⁇ glmL kanamycin.
  • the absorbance at 600 nm is >2.0, the cells are harvested by centrifugation (5,000 times g, 10 min in a GSA rotor at room temperature) and are re-suspended in 3 volumes of infiltration medium (1/times Murashige and Skoog salts, 1 times.
  • the Agrobacterium suspension is poured into a beaker and the potted plants are inverted into the beaker so that the bolts and entire rosettes are submerged.
  • the beaker is placed into a large Bell jar and a vacuum is drawn using a vacuum pump, until bubbles form on the leaf and stem surfaces and the solution starts to bubble a bit, and the vacuum is rapidly released.
  • Pots are removed from the beaker, are laid on their side in a plastic tray and are covered with a plastic dome, to maintain humidity. The following day, the plants are uncovered, set upright and are allowed to grow for approximately four weeks in a growth chamber under continuous light conditions as described by Katavic et al., (1995). When the siliques are mature and dry, seeds are harvested and selected for positive transformants.
  • Seeds are harvested from vacuum-infiltration transformation procedures, and are sterilized by treating for 1 min in ethanol and 5 min in. 50% bleach/0.05% TweenTM 20TM in sterile distilled water. The seeds are rinsed several times with sterile distilled water. Seeds are plated by re-suspending them in sterile 0.1% agarose at room temperature (about 1 mL agarose for every 500-1000 seeds), and applying a volume equivalent to about 2,000-4,000 seeds onto 150 ⁇ 15 mm selection plates (1/2 ⁇ Murashige and Skoog salts, 0.8% agar, autoclave, cool and add 1 ⁇ B5 vitamins and kanamycin at a final concentration of 50 ⁇ g/mL).
  • the plates are dried in a laminar flow hood until seed no longer flows when the plates are tipped.
  • the plates are vernalized for two nights at 4° C. in the dark, and are moved to a growth chamber (conditions as described by Katavic et al., 1995). After 7-10 days, transformants are clearly identifiable as dark green plants with healthy green secondary leaves and roots that extend over and into the selective medium.
  • Seedlings are transplanted to soil, plants are grown to maturity and mature seeds (T 2 generation as defined in Katavic et al., 1994) are collected and analyzed. T 2 seeds are propagated.
  • the vegetative growth patterns are monitored by measuring shoot tissue dry weights, and/or by counting the number of rosette leaves present by the time plants began to enter the generative (flower initiation) stage.
  • Floral initiation beginning of generative phase of growth
  • Floral initiation beginning of generative phase of growth
  • Data is reported in terms of percentage of plants flowering/bolting on a given day after planting (d.a.p.).
  • Cells or plants transformed with the LPC acyltransferase gene of the instant invention are grown to maturity and mature seeds are harvested.
  • Fatty acids are extracted from the cells or plants transformed with the LPC acyltransferase gene.
  • Normal-phase HPLC analysis is used to assay for the production of fatty acids in the transformed cells or plants.
  • LPCAT full-length or partial sequences of LPCAT from various plant species, including apple, barley, Capsicum annuum, castor bean, grapevine, maize, peach, rice, tomato, snapdragon, sorghum, sunflower, vaccinium corymbosum and wheat as well as Arabidopsis.
  • Sequence 1 (accession number Os02g0676000 (SEQ ID NO: 22)) MGLEMEGMAAAIGVSVPVLRFLLCFAATIPTGLMWRAVPGAAGRHLYAGL TGAALSYLSFGATSNLLFVVPMAFGYLAMLLCRRLAGLVTFLGAFGFLIA CHMYYMSGDAWKEGGIDATGALMVLTLKIISCAINYSDGMLKEEGLRDAQ KKYRLAKLPSLIEYFGYCLCCGSHFAGPVYEMKDYLEYTERKGLWASPTP SPLLPTLRALVQAGACMGLYLYLSPQFPLSRFSEPLYYEWGFWHRLFYQY MSGFTARWKYYFIWSLSEAAIIISGLGFSGWSDSSPPKAKWDRAKNVDVL GVELATSAVQLPLMWNIQVSTWLRYYVYERLVQKGKKPGFLQLLGTQTVS AVWHGLYPGYIIFFVQSALMINGSKVIYRWQQAVSNPVFHAILVFVNFSY TLMVLNY
  • Sequence 1 (accession number AAR99097 (SEQ ID NO: 38)) MLEPPKFIENDCYNGSRTFTWLADMVGLSVDLVNFLICQISALFLASLFR SMLHPSKVSSKLRHTFALSIGLAFGYFCFGQQAIHIAGLPAICYIVIRTQ DPRIVQRAVLLVAMSYLLCVHLMRQLYDYGSYALDITGPLMIITQKVTSL AFSIHDGFVRGDEELTKAQQYHAIRKMPSALEYFSYVWHFQSILAGPLVF YKDYIEFVEGYNLLSTPPGNGNLDSSKREVVLEPSPTKAVIRKVVGSLVC AFIFMKFVKIYPVKDMKEDDFMNNTSMVYKYWYAMMATTCIRFKYYHAWL LADAICNNSGLGFTGYDKDGNSKWDLISNINVLSFEFSTNMRDAINNWNC GTNRWLRTLVYERVPQQYGTLLTFALSAVWHGFYPGYYLTFATGAVVVTA
  • Sequence 1 (accession number EAX01013 (SEQ ID NO: 40)) MKCCFHHIIPRVNFVVCQLFALLAAIWFRTYLHSSKTSSFIRHVVATLLG LYLALFCFGWYALHFLVQSGISYCIMIIIGVENMHNYCFVFALGYLTVCQ VTRVYIFDYGQYSADFSGPMMIITQKITSLACEIHDGMFRKDEELTSSQR DLAVRRMPSLLEYLSYNCNFMGILAGPLCSYKDYITFIEGRSYHITQSGE NGKEETQYERTEPSPNTAVVQKLLVCGLSLLFHLTICTTLPVEYNIDEHF QATASWPTKIIYLYISLLAARPKYYFAWTLADAINNAAGFGFRGYDENGA ARWDLISNLRIQQIEMSTSFKMFLDNWNIQTALWLKRVCYERTSFSPTIQ TFILSAIWHGVYPGYYLTFLTGVLMTLAARAMRNNFRHYFIEPSQLKLFY
  • Sequence 1 (accession number AAH24653 (SEQ ID NO: 42)) MAARPPASLSYRTTGSTCLHPLSQLLGIPLDQVNFVACQL FALSAAFWFRIYLHPGKASPEVRHTLATILGIYFVVFCFGWYAVHLFVLV LMCYGVMVSASVSNIHRYSFFVAMGYLTICHISRIYIFHYGILTTDFSGP LMIVTQKITTLAFQVHDGLGRKAEDLSAEQHRLAVKAKPSLLEYLSYHLN FMSVIAGPCNNFKDYVAFIEGRHIHMKLLEVNWTQRGFQSLPEPSPTGAV IQKLCVTLMSLLLFLTLSKSFPVTFLIDDWFVHKANFLSRLWYLYVVMQA AKPKYYFAWTLADAVHNAAGFGFNGMDTDGKSRWDLLSNLNIWKIETATS FKMYLENWNIQTSTWLKCVCYERVSWYPTVLTFLLSALWHGVYPGY
  • Motif 1 M V(I) L(I) ⁇ ⁇ K L(V,I) ⁇ ⁇ ⁇ ⁇ ⁇ D G (or Met Xaa Xaa Xaa Xaa Lys Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Asp Gly (SEQ ID NO:46), wherein the Xaa at position 2 can be Val or Ile, the Xaa at position 3 can be Leu or Ile, the Xaa at position 7 can be Leu, Val, or Ile, while the other Xaa's in the motif may be any amino acid.
  • Motif 4 S A ⁇ W H G ⁇ ⁇ P G Y ⁇ ⁇ T(F) F (or Ser Ala Xaa Trp His Gly Xaa Xaa Pro Gly Tyr Xaa Xaa Xaa Phe (SEQ ID NO:49) wherein Xaa at position 14 is Thr or Phe, while the other Xaa's in the motif may be any amino acid.
  • FIG. 3 depicts another alignment of LPCAT sequences from different plant species that revealed the following motifs:
  • PCR primers were designed for nucleotide sequence of the putative TpLPCAT obtained by a BLAST search of the sequenced T. pseudonana genome using the yeast LPCAT sequence. Plasmid from a cDNA library of T. pseudonana was used as template.
  • a 50 ⁇ l PCR reaction contained 50 ng of plasmid DNA, 20 pM of each primer: 5′-GGTATGCTCATCTGCTACCCCCTC-3′ (SEQ ID NO:89) and 5′-TTAAGTCTCCTTCGTCTTTGGTGTAG-3′ (SEQ ID NO:90) and 1 ⁇ l of BD AdvantageTM 2 Polymerase Mix (Clontech Laboratories, Inc.), and was amplified in a thermocycler during 30 cycles of the following program: 94° C for 30 sec, 58° C. for 30 sec, and 72° C. for 1 min 30 sec.
  • the PCR product was purified, and subsequently cloned into the pYES2.1/V5-His-TOPO expression vector (Invitrogen).
  • TpLPCAT in yeast The TpLPCAT in pYES2.1/V5-His-TOPO plasmid was transformed into yeast lpcat mutant By02431 using the method provided by the producer's manual (Invitrogen). Yeast cells transformed with pYES2.1/V5-His-TOPO plasmid only were used as a control. Transformants were selected by growth on synthetic complete medium lacking uracil (SC-ura), supplemented with 2% (w/v) glucose. The colonies were transferred into liquid SC-ura with 2% (w/v) glucose and grown at 28° C. overnight.
  • SC-ura synthetic complete medium lacking uracil
  • the colonies were transferred into liquid SC-ura with 2% (w/v) glucose and grown at 28° C. overnight.
  • the overnight cultures were diluted to an OD 0.4 in induction medium (SC-ura+2% Galactose+1% Raffinose), and were induced by incubating at 28° C. for 24 hours.
  • the yeast cells were collected and broken using glass beads.
  • the protein concentrations in the lysates were normalized using the Biorad assay (Bradford 1976) and then assayed for LPCAT activity.
  • T. pseudonana LPCAT cDNA clone was amplified by PCR from an algae cDNA library.
  • the nucleotide sequence had an open reading frame of 1,323 bp encoding a polypeptide of 440 amino acids with a calculated molecular mass of 49.75 kD
  • TpLPCAT Expression of TpLPCAT in Yeast: To confirm the function of the protein encoded by the TpLPCAT, the full-length coding region of TpLPCAT was cloned into a yeast expression vector pYES2.1/V5-His-TOPO under the control of the galactose-inducible GAL1 promoter, and the construct was used to transform a LPCAT-deficient yeast strain By02431(a yeast lpcat strain). Yeast cells harboring an empty pYES2.1 vector plasmid were used as a control.
  • yeast lpcat strain is hypersensitive to lyso-PAF (lyso-Platelet-activating factor, 1-O-alkyl-sn-glycero-3-phosphocholine).
  • lyso-PAF lyso-Platelet-activating factor, 1-O-alkyl-sn-glycero-3-phosphocholine.
  • microsomal membrane fractions prepared from lysates of the induced yeast cells were assayed for LPCAT activity using 14C-labelled Lyso-PC as acceptor, and different unlabeled acyl-CoAs as acyl donors.
  • expression of the TpLPCAT in yeast lpcat mutant resulted in a restoration of LPCAT function and produced a recombinant LPCAT protein capable of incorporating a range of different acyl-CoAs into PC including 14:0-, 16:0-, 16:1-, 18:0-, 18:1-, 18:2-, and 22:6(DHA)-, with the most preference of 18:1-CoA, and efficiently utilization of the very long chain polyunsaturated fatty acid--22:6-CoA(DHA) ( FIGS. 5 & 6 ).
  • Yeast extract Yeast Nitrogen Base
  • Bacto-peptone Bacto-agar were purchased from DifcoTM, D-glucose, D-galactose and D-raffinose were from Sigma.
  • SC minimal medium and plates was prepared according to Invitrogen's recipe described for the pYES2.1 TOPO TA Cloning Kit.
  • Lyso-PAF sensitivity Yeast strains BY02431 carrying pYES 2.1-AtLPCATs or the empty vector were first grown in 15 ml of SC-Leu-His-ura medium containing 2% glucose. Yeast transformant strains of AtLPCATs were first grown in YPD overnight. Protein expression induction were carried out by protocol described in Invitrogen manufacturer manual for yeast expression vector pYES2.1. After 12 hr induction, 5 ⁇ l cultures were inoculated onto YPD plate with 10 ⁇ g/ml LysoPAF. The plates were incubated at 28° C. for 2 days. The final lysoPAF is 10 ⁇ g/ml.
  • Yeast strains BY02431 carrying pYES 2.1-AtLPCATs or the empty vector were first grown in 15 ml of SC-Leu-His-ura medium containing 2% glucose.
  • Yeast transformant strains of AtLPCATs were first grown in YPD overnight. Protein expression induction were carried out by protocol described in Invitrogen manufacturer manual for yeast expression vector pYES2.1.
  • the cells were washed first with distilled water and then with wall-breaking buffer (50 mM sodium phosphate, pH7.4; 1 mM EDTA; 1 mM PMSF; 5% glycerol) and spun down at 4,000 rpm (Eppendorf Centrifuge 5145C) to re-pellet cells.
  • the cells, resuspended in 1 ml cell wall-breaking buffer, were shaken vigorously in the presence of acid-washed glass beads (diameter 0.5 mm) in a mini-bead beater at 5,000 rpm for 3′ 1-min intervals.
  • the resultant homogenate was centrifuged at 1,500′ g for 5 min at 4° C.
  • the supernatant was decanted for in vitro assay. Protein concentration was measured using Bio-Rad Protein Assay Kit for final AtSAT1 activity calculation.
  • AtLPCAT substrate specificity was determined by counting incorporation of 14C-labeled lysophosphatidylcholine or 14C-labled palmityl-CoA into phosphatidylcholine. All assays were performed at least twice. 200 ml reaction mixture contained 50 mg microsomal protein, 50 mM acyl-CoA and 45 mM palmitoyl-PC, pH7.4. 14C-lysophosphatidylcholine (1.4 nCi/nmol) or 14C-palmityl-CoA (5.5 nCi/nmol) was used to assess fatty-CoA or lyso-lipid substrate specificity. Reaction was allowed for 10 min at 30° C. All radiolabel chemicals for these assays were purchased from ARC, Inc.
  • Lyso-PAF sensitivity test ( FIG. 7 ): The yeast lpcat strain is deficient in its endogenous LPCAT and hypersensitive to lyso-PAF (lyso-Platelet-activating factor, 1-O-alkyl-sn-glycero-3-phosphocholine). The lpcat yeast mutant is incapable of growth in the presence of 10 ug/ml lyso-PAF (lyso-Platelet-activating factor, 1-O-alkyl-sn-glycero-3-phosphocholine).
  • Lyso-lipid substrate specificity ( FIG. 8 ): LPA (lysophosphatidic acid), LPC (lysophosphatidic choline), LPE (lysophosphatidylethanolamine), LPG (lysophosphatidylglycerol), LPI (lysophosphatidyl inositol) and LPS (lysophosphatidyl serine) were first tested as substrates to compare their acyltransferase activity. The results clearly showed that Atlg12640 and Atlg63050 both exhibited high activity towards LPC ( FIG. 8 ).

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Nucleic acid molecules identified in encode lyso-phosphatidylcholine (LPC) acyltransferases. Over-expression of the LPC acyltransferases in a cell may lead to enhanced production of PUFA, or other unusual fatty acids, and/or to increased oil content in the cell.

Description

    CROSS-REFERENCE TO RELATED APPLICATION
  • This application claims the benefit, under 35 U.S.C. § 119(e) of U.S. Provisional Patent Application Ser. No. 60/874,497 filed Dec. 13, 2006, the contents of the entirety of which is incorporated by this reference.
  • TECHNICAL FIELD
  • The invention relates generally to biotechnology, and, more particularly, to lyso-phosphatidylcholine (LPC) acyltransferase, polynucleotides that encode LPC acyltransferases, and associated methods.
  • BACKGROUND
  • Phosphatidylcholine (PC) serves not only as a major component of cellular membranes, but also as a major source of fatty acyl donors for triacylglycerol biosynthesis in eukaryotic organisms. At least three pathways through which PC is generated exist: (i) the CDP-choline pathway where diacylglycerol (DAG) is a direct precursor; (ii) a pathway where CDP-DAG is a direct precursor, involving phosphatidylserine formation and decarboxylation and phosphatidylethanolamine methylation (Zheng and Zou, 2001); and (iii) a pathway with LPC as substrate. The third pathway is exerted by LPC acyltransferases (LPCAT).
  • LPCAT enzymes catalyze the acylation of LPC molecules to form PC and play a pivotal role in membrane biogenesis. They can also exert a reversible reaction to release the fatty acyl chain esterified to the sn-2 position of PC, thereby contributing to a continuous remodeling of fatty acyl-CoA and PC pools.
  • The significance of LPCAT in glycerolipid metabolism of eukaryotic systems has been noted for many years. For genetic engineering of plant-based production of very long chain polyunsaturated fatty acid (PUFA), this enzyme is believed to represent a bottleneck for acyl exchange between the fatty acyl elongation and de-saturation systems. In higher plants, the function of this enzyme is largely unknown, but it has been proposed that the enzyme is involved in the selective incorporation of fatty acids into storage pool.
  • Although LPCAT relating to the synthesis of surfactant lipid located on the surface of (pulmonary) cells have been reported in mammalian systems (Chen X et al., PNAS 2006 103:11724-11729; Nakanishi H et al., JBC 2006 281: 20140-20147), an LPC transferase involved in membrane or storage lipid synthesis has not been reported.
  • Recently, a mitochondrial acyl-CoA independent LPCAT from Saccharomyces cerevisiae has been identified. This enzyme has been shown to function in cardiolipin metabolism (Testet et al. 2005). In addition, Shindou et al. (2007) reported that aceyl-CoA:lyso-PAF (platelet-activating factor) acetyltransferase possesses LPCAT activity.
  • SUMMARY OF THE INVENTION
  • Novel types of LPCAT enzymes whose sequences are unrelated to any known LPCAT enzymes have been identified.
  • Previously reported LPCAT share a substantial sequence homology to glycerol-3-phosphate acyltransferase and lysophosphatidic acyltransferase. In contrast, the LPCAT sequences disclosed herein are unrelated to any known LPCAT sequences, and belong to a new class of LPCAT. Four conserved motifs were identified in this novel class of LPCAT enzymes. The identified motifs are different from previously reported LPCAT, which contain motifs having a high degree of similarity to those in other known acyltransferases employing glycerol-3-phosphate and lysophosphatidic acid as substrates. In contrast, sequence information of the motifs identified herein is novel, and can lead to the identification of new class of LPCAT genes from a broad spectrum of species.
  • Thus, in certain embodiments, a lyso-phosphatidylcholine acyltransferase gene or class of genes is identified. The LPC acyltransferase gene may be expressed or overexpressed in a cell and used to modify glycerolipid biosynthesis in a cell. Such an LPC acyltransferase gene may be expressed or overexpressed in a cell and used to modulate or enhance production of fatty acids, especially polyunsaturated fatty acids (PUFA) or other unusual fatty acids, and/or to increased oil content in the cell. The LPC acyltransferase gene may be expressed or overexpressed in planta in order to modify glycerolipid biosynthesis in a plant. In certain embodiments, the LPC acyltransferase gene is expressed or overexpressed in planta in order to enhance the production of fatty acids in a plant.
  • In certain embodiments, a plant, plant seed or progeny thereof includes a recombinant cell having an LPC acyltransferase gene.
  • In certain embodiments, a vector is provided having an LPC acyltransferase gene. The vector may be used to transform a cell, thus producing a recombinant cell having the LPC acyltransferase gene. The cell may comprise, for example, a bacterial cell, a yeast cell, or a plant cell.
  • In certain embodiments, a recombinant cell expresses an LPC acyltransferase gene and produces an LPC acyltransferase polypeptide that may be isolated or purified from the cell.
  • In certain embodiments, nucleotide and deduced amino acid sequences associated with an LPC acyltransferase gene are disclosed. The sequence, or a portion thereof, may be used to identify genes from other species that encode polypeptides with LPC acyltransferase activity.
  • In certain embodiments, a process for producing fatty acids includes transforming a cell with an LPC acyltransferase gene. The transformed cell expresses the fatty acid acyltransferase gene and produces fatty acids. The fatty acids may be isolated or purified from the recombinant cell or culture media in which the cell grows, and subsequently incorporated into a composition.
  • In certain embodiments, knock-out mutants disrupted in LPC acyltransferase gene of yeast and plants are identified.
  • In certain embodiments, a peptide comprising one or more of the four motifs may be used as an LPC Acyltransferase. Similarly, a nucleotide sequence encoding a peptide comprising one or more of the four motifs may be used as an LPC Acyltransferase.
  • Also provided is an isolated or recombinant nucleic acid molecule encoding an LPC acyltransferase, and a cell transformed with the isolated or recombinant nucleic acid molecule as described herein. Also provided is a process for increasing fatty acid production in a cell, the process comprising: transforming a cell with a nucleic acid molecule encoding an LPC acyltransferase; and, growing the cell under conditions wherein said LPC acyltransferase is expressed. Also provided is a use of an isolated or recombinant nucleic acid molecule encoding an LPC acyltransferase for producing an LPC acyltransferase in a cell. Also provided is a purified or an isolated LPC acyltransferase.
  • LPCAT enzymes play a critical role in remodeling fatty acid and PC pools as well as PC synthesis. The remodeled fatty acyl chains in the form of acyl-CoA or esterified at the sn-2 position of PC can be used for triacylglycerol synthesis. Thus, this novel type of LPCAT isolated from the organisms where very-long-chain polyunsaturated fatty acids (VLCPUFA) are present at a high level can be used to increase the production of VLCPUFA. As well, this novel type of LPCAT isolated from species containing high amount of unusual fatty acids can be used to increase the production of unusual fatty acids. For instance, LPCAT enzymes isolated from castor bean are useful in increasing the production of hydroxyl fatty acids in oil seeds.
  • The enzyme activity described herein provides support that the motif-based gene searching is a useful approach.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 is a graph of LPCAT activity (nmol/mg·h) of wild type (WT) and YOC175c mutant yeast strains.
  • FIG. 2 is an alignment of LPCAT sequences from different species that revealing, among other things, four conserved motifs unique for this type of LPCAT enzymes.
  • FIG. 3 is another alignment of LPCAT sequences from different plant species that revealed four conserved motifs (SEQ ID NOS: 81-84).
  • FIG. 4 is depicts the expression of the TpLCAT in lpcat mutant was able to complement the sensitivity of the lpcat mutant to Lyso-PAF.
  • FIG. 5 is a graph showing the expression of TpLPCAT in yeast. LPCAT assays were performed on cell lysates of yeast lpcat mutant strain By02431 transformed with TpLPCAT/pYES2.1 and pYes2.1/V5-His-TOPO plasmid only (control) in the presence of 14C-Lyso-PC and different acyl-CoAs.
  • FIG. 6 comprises TLC plates of LPCAT assays on cell lysates of yeast lpcat mutant strain By02431 transformed with TpLPCAT/pYES2.1 and pYes2.1/V5-His-TOPO plasmid only (control) in the presence of 14C-Lyso-PC and different acyl-CoAs. 1, 3, 5, 7, 9, 11, and 13-TpLPCAT; 2, 4, 6, 8, 10, 12, and 14-empty vector.
  • FIG. 7 shows a LysoPAF sensitivity test of YOR175c mutant, AtLPCATs transformant, wherein A is VO/BY02431, B is AtLPCAT1/BY02431, and C is AtLPCAT2/BY02431.
  • FIG. 8 is a graph showing the Lyso-lipid substrate specificity of Arabidopsis LPCATs.
  • DESCRIPTION OF PREFERRED EMBODIMENTS
  • Preferably, the nucleic acid molecule encoding the LPC acyltransferase is derived from yeast, plant and mammal species. Yeast species include, for example, species of the genus Saccharomyces, for example Saccharomyces cerevisiae. Plant species include, for example, species of the family Brassicaceae. Of the family Brassicaceae, species of genus Brassica and genus Arabidopsis are of particular note, for example Arabidopsis thaliana. Mammalian species include mouse and human.
  • In particular, provided are a nucleic acid molecule encoding an LPC acyltransferase from S. cerevisiae and two nucleic acid molecules encoding two different isoforms of LPC acyltransferase from A. thaliana. There is also provided the LPC acyltransferases encoded by the aforementioned nucleic acid molecules.
  • Provided herein is an isolated or recombinant nucleic acid molecule having a nucleotide sequence encoding an LPC acyltransferase such as amino acid sequence comprising SEQ ID NO: 2, SEQ ID NO: 4, SEQ ID NO: 6, SEQ ID NO: 8, SEQ ID NO:10, SEQ ID NO:11; SEQ ID NO:13, SEQ ID NO:15, SEQ ID NO:17; SEQ ID NO:19, SEQ ID NO:21, SEQ ID NO:25, SEQ ID NO:27, SEQ ID NO:29, SEQ ID NO:31, SEQ ID NO:33, and SEQ ID NO:35. In particular, there is provided an isolated or recombinant nucleic acid molecule having a nucleotide sequence comprising SEQ ID NO: 1, SEQ ID NO: 3, SEQ ID NO: 5, SEQ ID NO: 7, SEQ ID NO:9, SEQ ID NO:12, SEQ ID NO:14, SEQ ID NO:16, SEQ ID NO:18, SEQ ID NO:20, SEQ ID NO:24, SEQ ID NO:26, SEQ ID NO:28, SEQ ID NO:30, SEQ ID NO:32, or SEQ ID NO:34. Preferably, the LPC acyltransferase encoded by a nucleic acid molecule comprises an amino acid sequence comprises an amino acid sequence having at least 60% homology to the aforementioned sequences. Homology is more preferably at least 70%, 80%, 90%, or 95%. It will be appreciated that this disclosure embraces the degeneracy of codon usage as would be understood by one of ordinary skill in the art.
  • Homologs of the LPC acyltransferase genes described herein obtained from other organisms, for example plants, may be obtained by screening appropriate libraries that include the homologs, wherein the screening is performed with the nucleotide sequence of the specific LPC acyltransferase genes of the instant invention or portions or probes thereof, or identified by sequence homology search using sequence alignment search programs such as BLAST, FASTA.
  • Further included are nucleic acid molecules that hybridize to the above disclosed sequences. Hybridization conditions may be stringent in that hybridization will occur if there is at least a 90%, 95% or 97% identity with the nucleic acid molecule that encodes the LPC acyltransferase of the instant invention. The stringent conditions may include those used for known Southern hybridizations such as, for example, incubation overnight at 42° C. in a solution having 50% formamide, 5×SSC (150 mM NaCl, 15 mM trisodium citrate), 50 mM sodium phosphate (pH 7.6), 5×Denhardt's solution, 10% dextran sulfate, and 20 micrograms/milliliter denatured, sheared salmon sperm DNA, following by washing the hybridization support in 0.1×SSC at about 65° C. Other known hybridization conditions are well known and are described in Sambrook et al., Molecular Cloning: A Laboratory Manual, Third Edition, Cold Spring Harbor, N.Y. (2001), incorporated herein in its entirety by this reference.
  • Nucleic acid molecules that code for an LPC acyltransferase may be transformed into an organism, for example a plant. As known in the art, there are a number of ways by which genes and gene constructs can be introduced into organisms, for example plants, and a combination of transformation and tissue culture techniques have been successfully integrated into effective strategies for creating transgenic organisms, for example crop plants. These methods, which can be used in the invention, have been described elsewhere (Potrykus, 1991; Vasil, 1994; Walden and Wingender, 1995; Songstad et al., 1995), and are well known to persons skilled in the art. For example, one skilled in the art will certainly be aware that, in addition to Agrobacterium-mediated transformation of Arabidopsis by vacuum infiltration (Bechtold et at., 1993) or wound inoculation (Katavic et al., 1994), it is equally possible to transform other plant and crop species, using Agrobacterium Ti-plasmid-mediated transformation (e.g., hypocotyl (DeBlock et al., 1989) or cotyledonary petiole (Moloney et al., 1989) wound infection), particle bombardment/biolistic methods (Sanford et al., 1987; Nehra. et al., 1994; Becker et al., 1994) or polyethylene glycol-assisted, protoplast transformation (Rhodes et al., 1988; Shimamoto et al., 1989) methods.
  • As will also be apparent to persons skilled in the art, and as described elsewhere (Meyer, 1995; Dada et al., 1997), it is possible to utilize plant promoters to direct any intended up- or down-regulation of transgene expression using constitutive promoters (e.g., those based on CaMV35S), or by using promoters which can target gene expression to particular cells, tissues (e.g., napin promoter for expression of transgenes in developing seed cotyledons), organs (e.g., roots), to a particular developmental stage, or in response to a particular external stimulus (e.g., heat shock).
  • Promoters for use herein may be inducible, constitutive, or tissue-specific or have various combinations of such characteristics. Useftil promoters include, but are not limited to constitutive promoters such as carnation etched ring virus (CERV), cauliflower mosaic virus (CaMV) 35S promoter, or more particularly the double enhanced cauliflower mosaic virus promoter, comprising two CaMV 35S promoters in tandem (referred to as a “Double 35S”promoter).
  • It may be desirable to use a tissue-specific or developmentally regulated promoter instead of a constitutive promoter in certain circumstances. A tissue-specific promoter allows for overexpression in certain tissues without affecting expression in other tissues. By way of illustration, a preferred promoter used in overexpression of enzymes in seed tissue is an ACP promoter as described in PCT International Publication WO 92/18634, published Oct. 29, 1992, the disclosure of which is herein incorporated by reference.
  • The promoter and termination regulatory regions will be functional in the host plant cell and may be heterologous (that is, not naturally occurring) or homologous (derived from the plant host species) to the plant cell and the gene. Suitable promoters which may be used are described above.
  • The termination regulatory region may be derived from the 3′ region of the gene from which the promoter was obtained or from another gene. Suitable termination regions which may be used are well known in the art and include Agrobacterium tumefaciens nopaline synthase terminator (Tnos), A. tumefaciens mannopine synthase terminator (Tmas) and the CaMV 35S terminator (T35S). Particularly preferred termination regions for use herein include the pea ribulose bisphosphate carboxylase small subunit termination region (TrbcS) or the Tnos termination region. Such gene constructs may suitably be screened for activity by transformation into a host plant via Agrobacterium and screening for increased isoprenoid levels.
  • Suitably, the nucleotide sequences for the genes may be extracted from the GenBank® (a registered trademark of the U.S. Department of Health and Human Services) nucleotide database and searched for restriction enzymes that do not cut. These restriction sites may be added to the genes by conventional methods such as incorporating these sites in PCR primers or by sub-cloning.
  • Preferably, a DNA construct for use herein is comprised within a vector, most suitably an expression vector adapted for expression in an appropriate host (plant) cell. It will be appreciated that any vector which is capable of producing a plant comprising the introduced DNA sequence will be sufficient.
  • Suitable vectors are well known to those skilled in the art and are described in general technical references such as Pouwels et al., Cloning Vectors. A Laboratory Manual, Elsevier, Amsterdam (1986). Particularly suitable vectors include the Ti plasmid vectors.
  • Transformation techniques for introducing the DNA constructs into host cells are well known in the art and include such methods as micro-injection, using polyethylene glycol, electroporation, or high velocity ballistic penetration. A preferred method relies on Agrobacterium-mediated transformation. After transformation of the plant cells or plant, those plant cells or plants into which the desired DNA has been incorporated may be selected by such methods as antibiotic resistance, herbicide resistance, tolerance to amino-acid analogues or using phenotypic markers.
  • Various assays may be used to determine whether the plant cell shows an increase in gene expression, for example, Northern blotting or quantitative reverse transcriptase PCR (RT-PCR). Whole transgenic plants may be regenerated from the transformed cell by conventional methods. Such transgenic plants having improved isoprenoid levels may be propagated and self-pollinated to produce homozygous lines. Such plants produce seeds containing the genes for the introduced trait and can be grown to produce plants that will produce the selected phenotype.
  • Plants that may be modified or used for fatty acid production according to the instant invention include, without limitation, borage (Borago spp.), Canola, castor (Ricinus communis); cocoa bean (Theobroma cacao), corn (Zea mays), cotton (Gossypium spp), Crambe spp., Cuphea spp., flax (Linum spp.), Lesquerella and Limnanthes spp., Linola, nasturtium (Tropaeolum spp.), Oeanothera spp., olive (Olea spp.), palm (.Elaeis spp.), peanut (Arachis spp.), rapeseed, safflower (Carthamus spp.), soybean (Glycine and Soja spp.), sunflower (Helianthus spp.), tobacco (Nicotiana spp.), Vernonia spp., wheat (Triticum spp.), barley (Hordeum spp.), rice (Oryza spp.), oat (Avena spp.) sorghum (Sorghum spp.), rye (Secale spp.) or other members of the Gramineae. It will further be apparent to those of ordinary skill in the art that genomic or sequence libraries of each of these plants may be screened with the nucleotide or amino acid sequences described herein (e.g., for one or more of the hereinafter identified conserved motifs (SEQ ID NO:46 through SEQ ID NO:49) for other sequences that encode or are homologous to sequences associated with the LPC acyltransferase of the instant invention.
  • Plants transformed with a nucleotide sequence of the instant invention that codes for an LPC acyltransferase may be grown. Seeds of the transgenic plants are harvested and fatty acids of the seeds are extracted. The extracted fatty acids are used for subsequent incorporation into a composition, for example a pharmaceutical composition, a nutraceutical composition or a food composition.
  • In certain embodiments, a peptide comprising one or more of the four motifs may be used as an LPC Acyltransferase. Similarly, a nucleotide sequence encoding a peptide comprising one or more of the four motifs may be used as an LPC Acyltransferase.
  • In certain embodiments, other methods of enhancing or altering oil production may also be used with the plant to be transformed (e.g., incorporating, for expression in the plant, a nucleic acid sequence selected from the group consisting of a nucleic acid sequence encoding a peptide having, for example, Brassica pyruvate dehydrogenase kinase activity (see, e.g., U.S. Pat. No. 7,214,859 to Marilla et al. (May 8, 2007), U.S. Pat. No. 6,500,670 to Zou et al. (Decemer 2002), and U.S. Pat. No. 6,256,636 to Randall et al. (July 2001), the contents of the entirety of each of which is incorporated herein by this reference), a nucleic acid sequence encoding a peptide having diacylglycerol acyltransferase activity (see, e.g., U.S. Pat. No. 7,015,373 and U.S. Pat. No. 6,500,670 to Zou et al. (December 2002), the contents of the entirety of each of which is incorporated herein by this reference), a nucleic acid sequence encoding a peptide having glycerol-3-phosphate dehydrogenase activity (see, e.g., U.S. Pat. No. 7,112,724, the contents of the entirety of which is incorporated herein by this reference), and combinations thereof).
  • Also described is a method of transforming a cell or a plant, the method comprising introducing the isolated, purified or recombinant nucleic acid into the cell or plant. A process for producing a genetically transformed plant seed comprises introducing the nucleic acid into the plant seed.
  • Also described is a vector comprising SEQ ID NO: 1, SEQ ID NO: 3, SEQ ID NO: 5, SEQ ID NO: 7, SEQ ID NO:9, SEQ ID NO:12, SEQ ID NO:14, SEQ ID NO:16, SEQ ID NO:18, SEQ ID NO:20, SEQ ID NO:24, SEQ ID NO:26, SEQ ID NO:28, SEQ ID NO:30, SEQ ID NO:32, and/or SEQ ID NO:34.
  • Also described is a vector comprising a nucleic acid sequence encoding a polypeptide having lyso-phosphatidylcholine acyltransferase activity, wherein the nucleic acid sequence comprises SEQ ID NO: 1, SEQ ID NO: 3, SEQ ID NO: 5, SEQ ID NO: 7, SEQ ID NO:9, SEQ ID NO:12, SEQ ID NO: 14, SEQ ID NO:16, SEQ ID NO:18, SEQ ID NO:20, SEQ ID NO:24, SEQ ID NO:26, SEQ ID NO:28, SEQ ID NO:30, SEQ ID NO:32, or SEQ ID NO:34, or a fragment of SEQ ID NO: 1, SEQ ID NO: 3, SEQ ID NO: 5, SEQ ID NO: 7, SEQ ID NO:9, SEQ ID NO:12, SEQ ID NO:14, SEQ ID NO:16, SEQ ID NO:18, SEQ ID NO:20, SEQ ID NO:24, SEQ ID NO:26, SEQ ID NO:28, SEQ ID NO:30, SEQ ID NO:32, or SEQ ID NO:34, or having 90% identity with SEQ ID NO: 1, SEQ ID NO: 3, SEQ ID NO: 5, SEQ ID NO: 7, SEQ ID NO:9, SEQ ID NO:12, SEQ ID NO:14, SEQ ID NO:16, SEQ ID NO:18, SEQ ID NO:20, SEQ ID NO:24, SEQ ID NO:26, SEQ ID NO:28, SEQ ID NO:30, SEQ ID NO:32, or SEQ ID NO:34, wherein the fragment encodes the polypeptide having the lyso-phosphatidylcholine acyltransferase activity.
  • Also described is a method for increasing fatty acid production in a cell, the method comprising transforming a cell with a nucleic acid molecule encoding a lyso-phosphatidylcholine acyltransferase; and growing the cell under conditions wherein the lyso-phosphatidylcholine acyltransferase is expressed. The method can further comprise isolating the fatty acid. In such a method, the lyso-phosphatidylcholine acyltransferase preferably comprises at least one motif selected from the group consisting of SEQ ID NO: 46, SEQ ID NO: 47, SEQ ID NO: 48, SEQ ID NO: 49, and any combination thereof.
  • Also described is a method of altering oil content in a plant comprising screening for a peptide encoded by a nucleotide sequence for at least one of four motifs selected from the group consisting of SEQ ID NO: 46, SEQ ID NO: 47, SEQ ID NO: 48, and SEQ ID NO: 49; selecting the peptide based upon the presence of at least one of the four motifs; and expressing the nucleotide sequence encoding the peptide in the plant to alter the oil content of the plant.
  • Also described is a method of changing the oil content of a plant or plant seed, the method comprising introducing a nucleic acid construct comprising a nucleic acid sequence encoding a polypeptide selected from the group consisting of SEQ ID NO: 2, SEQ ID NO: 4, SEQ ID NO: 6, SEQ ID NO: 8, SEQ ID NO:10, SEQ ID NO:11; SEQ ID NO:13, SEQ ID NO:15, SEQ ID NO:17; SEQ ID NO:19, SEQ ID NO:21, SEQ ID NO:25, SEQ ID NO:27, SEQ ID NO:29, SEQ ID NO:31, SEQ ID NO:33, SEQ ID NO:35, and an amino acid sequence having at least 60% homology to any thereof having lyso-phosphatidylcholine acyltransferase activity into a plant transformation vector; transforming a genome of a plant or plant seed with the plant transformation vector; expressing the nucleic acid sequence; growing the plant or plant seed; and extracting the oil from the plant seed.
  • The methods can further comprise incorporating, for expression in the plant, a nucleic acid sequence selected from the group consisting of a nucleic acid sequence encoding a peptide having pyruvate dehydrogenase kinase activity, a nucleic acid sequence encoding a peptide having diacylglycerol acyltransferase activity, a nucleic acid sequence encoding a peptide having glycerol-3-phosphate dehydrogenase activity, and any combination thereof.
  • The methods preferably involve a plant of the group consisting of borage (Borago spp.), Canola, castor (Ricinus communis); cocoa bean (Theobroma cacao), corn (Zea mays), cotton (Gossypium spp), Crambe spp., Cuphea spp., flax (Linum spp.), Lesquerella and Limnanthes spp., Linola, nasturtium (Tropaeolum spp.), Oeanothera spp., olive (Olea spp.), palm (.Elaeis spp.), peanut (Arachis spp.), rapeseed, safflower (Carthamus spp.), soybean (Glycine and Soja spp.), sunflower (Helianthus spp.), tobacco (Nicotiana spp.), Vernonia spp,, wheat (Triticum spp.), barley (Hordeum spp.), rice (Oryza spp.), oat (Avena spp.) sorghum (Sorghum spp.), rye (Secale spp.) or other members of the Gramineae.
  • The invention is further described with the aid of the following illustrative Examples.
  • EXAMPLE 1 Identification of Yeast LPC Acyltransferase Gene
  • Nucleotide sequences of nucleic acid molecules of the invention were identified through yeast genetic and functional screening. Yeast (S. cerevisiae) LPC acyltransferase gene was identified based on enzyme assays of yeast mutant strains in which the gene, YOR175c, was knocked out. The enzyme activity was assessed using 14C-labeled acyl-CoA and lyso-phosphatidylcholine. The reaction product of the lyso-phosphatidylcholine and radio-labeled acyl-CoA was separated through TLC and measured through scintillation counting. Deletion of the YOR175c gene in yeast resulted in a 90% reduction of LPC acyltransferase activity (FIG. 1). Therefore, YOR175c encodes LPC acyltransferase. Details are given below for the In Vitro Assay protocol for LPCAT (lyso-phosphatidylcholine (LPC) acyltransferase) activity.
  • Yeast culture: One colony each of wild-type (strain BY4741) and LPCAT mutants (YOR175c deletion strains Y12431, Y02431) are inoculated in 10 ml YPD media and grown overnight. After 24 hr, another 20 ml YPD media is added and growth is continued for another 24 hr.
  • Protein extraction: Yeast cultures are spun at 2800 rpm at 4° C. for 20 min. The supernatant is discarded and the yeast pellet washed with 10 ml of ice cold IB buffer (80 mM HEPES, 320 mM sucrose, 5 mM EDTA pH8, 10 mM KCl, 2 mM DTT). The pellets are spun again and re-suspend in 500 μl of IB buffer. Yeast cells are divided and transferred into 2 tubes appropriate for a mini-bead beater. 0.5 mm cold glass beads are added to fill completely the tube. To break the yeast cell, three 60 s pulses of the mini-bead beater are used. The mixtures are spun again to remove unbroken cells and debris.
  • Protein assay conditions: A reaction is conducted using the recipe for fatty-CoA substrate specificity, as listed in Table 1.
  • TABLE 1
    Solution Volume added
    450 μM lyso-PC (18:1) 50 μl
    180 μM 14C 18:1-CoA (10 nCi/nmol) 50 μl
    Microsome 400 μg protein
    pH 7.4 HEPES to make fine volume 0.5 ml
  • The reaction mixture is allowed to sit in a water bath at 30° C. and stirred at 100 rpm for 30 min. The reaction is then terminated by adding 2 ml of CH2Cl2: Isopropanol (1:2). The mixture is allowed to sit at room temperature for 15-30 min with occasional vortexing. Phases are separated by adding 2 ml CH2Cl2 followed by 2 ml IM KCl in H3PO4. The lower layer is transferred to a clean tube and the upper aqueous phase is backwashed twice with CH2Cl2 and centrifuged, saving the organic phase each time. Organic phases are combined and dried under nitrogen. Dried material is taken up in 200 μl CH2Cl2: MeOH (2:1) and protein is separated by thin layer chromatography (TLC) using silica G (250 μm) commercial plate. Plates are developed to within 2 cm of top in ethyl acetate:isooctane:acetic acid (45:15:10, V/V/V), then dried and scraped. The phosphatidyl choline region is counted in 4 ml Aquasol-2 by a scintillation counter.
  • The YOR175c gene from S. cerevisiae has been identified as encoding an LPC acyltransferase. The coding sequence of this yeast LPC acyltransferase gene is SEQ ID NO: 1:
  • ATGTACAATCCTGTGGACGCTGTTTTAACAAAGATAATTACCAACTATGGGATTGATAGT
    TTTACACTGCGATATGCTATCTGCTTATTGGGATCGTTCCCACTGAATGCTATTTTGAAG
    AGAATTCCCGAGAAGCGTATAGGTTTAAAATGTTGTTTTATCATTTCTATGTCGATGTTT
    TACTTATTCGGTGTGCTGAATCTAGTAAGTGGATTCAGGACCCTGTTTATTAGTACCATG
    TTTACTTACTTGATCTCAAGATTTTACCGTTCCAAGTTTATGCCACACTTGAATTTCATG
    TTTGTTATGGGTCATTTGGCAATAAATCATATACACGCCCAATTCCTTAACGAACAGACT
    CAAACTACCGTTGACATTACAAGTTCACAAATGGTTTTAGCCATGAAACTAACTTCTTTT
    GCATGGTCGTACTATGATGGTTCATGCACTAGCGAAAGCGATTTCAAAGATTTGACTGAG
    CATCAAAAATCTCGTGCTGTCAGAGGTCATCCACCCTTATTAAAGTTCCTGGCATATGCA
    TTTTTCTATTCAACGTTGCTAACTGGCCCAAGTTTCGATTATGCCGATTTTGACAGCTGG
    TTGAATTGTGAGATGTTCCGTGACTTGCCTGAAAGCAAAAAGCCTATGAGAAGACACCAC
    CCTGGTGAAAGAAGACAGATTCCAAAGAATGGTAAACTTGCATTATGGAAAGTTGTTCAA
    GGTCTTGCTTGGATGATTTTAAGTACACTAGGAATGAAGCACTTCCCCGTAAAATACGTT
    TTGGACAAAGATGGCTTCCCAACGAGATCTTTTATATTCAGAATCCATTACTTATTCTTG
    CTTGGTTTCATCCATAGATTCAAGTACTACGCTGCCTGGACTATTTCGGAAGGATCTTGT
    ATTTTGTGCGGTTTGGGTTATAATGGTTATGATTCAAAGACACAAAAGATCAGATGGGAT
    CGTGTCAGAAATATTGACATTTGGACCGTAGAAACGGCGCAGAATACGCGTGAAATGTTG
    GAAGCATGGAATATGAATACTAACAAGTGGCTAAAATACTCTGTTTATTTACGTGTCACA
    AAGAAGGGCAAAAAACCTGGTTTCCGCTCAACTTTGTTTACTTTCCTAACTTCCGCATTT
    TGGCATGGTACCAGACCTGGGTACTATCTGACTTTTGCGACAGGGGCTTTGTACCAAACA
    TGTGGTAAAATCTACAGACGCAATTTTAGACCAATTTTCTTGCGAGAAGATGGTGTCACT
    CCTTTGCCTTCTAAAAAAATCTACGATTTAGTTGGCATATATGCAATTAAACTAGCATTT
    GGTTACATGGTGCAACCATTTATTATCCTTGATTTGAAGCCATCTTTAATGGTATGGGGC
    TCTGTTTATTTCTATGTTCATATTATTGTTGCTTTCTCATTTTTCCTATTCAGAGGACCA
    TATGCTAAACAAGTTACTGAATTTTTTAAATCCAAACAACCTAAAGAAATATTCATTAGA
    AAACAAAAGAAGTTGGAAAAAGATATTTCTGCAAGCTCTCCAAACTTGGGTGGTATATTG
    AAGGCAAAGATTGAACATGAAAAGGGAAAGACAGCAGAAGAAGAAGAAATGAACTTAGGT
    ATTCCACCAATTGAGTTAGAAAAGTGGGACAATGCTAAGGAAGATTGGGAAGATTTCTGC
    AAAGATTACAAAGAATGGAGAAATAAAAATGGTCTTGAAATAGAAGAGGAAAACCTTTCT
    AAAGCTTTTGAAAGATTCAAGCAGGAATTTTCTAACGCTGCAAGTGGATCAGGTGAACGT
    GTGAGAAAAATGAGTTTTAGTGGTTACTCACCAAAGCCTATTTCAAAAAAGGAAGAGTAG
  • The deduced amino acid sequence of the yeast LPC acyltransferase encoded by the gene is SEQ ID NO: 2:
  • MYNPVDAVLTKIITNYGIDSFTLRYAICLLGSFPLNAILKRIPEKRIGLKCCFIISMSMF
    YLFGVLNLVSGFRTLFISTMFTYLISRFYRSKFMPHLNFMFVMGHLAINHIHAQFLNEQT
    QTTVDITSSQMVLAMKLTSFAWSYYDGSCTSESDFKDLTEHQKSRAVRGHPPLLKFLAYA
    FFYSTLLTGPSFDYADFDSWLNCEMFRDLPESKKPMRRHHPGERRQIPKNGKLALWKVVQ
    GLAWMILSTLGMKHFPVKYVLDKDGFPTRSFIFRIHYLFLLGFIHRFKYYAAWTISEGSC
    ILCGLGYNGYDSKTQKIRWDRVRNIDIWTVETAQNTREMLEAWNMNTNKWLKYSVYLRVT
    KKGKKPGFRSTLFTFLTSAFWHGTRPGYYLTFATGALYQTCGKIYRRNFRPIFLREDGVT
    PLPSKKIYDLVGIYAIKLAFGYMVQPFIILDLKPSLMVWGSVYFYVHIIVAFSFFLFRGP
    YAKQVTEFFKSKQPKEIFIRKQKKLEKDISASSPNLGGILKAKIEHEKGKTAEEEEMNLG
    IPPIELEKWDNAKEDWEDFCKDYKEWRNKNGLEIEEENLSKAFERFKQEFSNAASGSGER
    VRKMSFSGYSPKPISKKEE
  • EXAMPLE 2 Identification of Plant Nucleotide Sequences Encoding LPC Acyltransferase
  • The nucleotide sequence of the yeast LPC acyltransferase gene was used to search for homologous sequences using computer programs designed to search for homologous sequences. For instance, readily commercially available computer programs that may be used for such searches include without limitation, BLASTN, BLASTX and TBLASTX which may be used to search for nucleotide sequences, and BLASTP and TBLASTN which may be used to search for amino acid sequences. Such computer programs are readily accessible at the web-site www.ncbi.nlm.nih.gov.
  • Two plant (A. thaliana) homologs were identified through sequence alignment searching using BLAST. The two homologs are cDNA sequences that encode two different isoforms of LPC acyltransferase.
  • Arabidopsis LPC acyltransferase 1
  • Nucleotide sequence of Arabidopsis LPC acyltransferase 1 cDNA is SEQ ID NO: 3:
  • 1 ACCAACAACC ACACGACACG ACACGACCGA TCTATAGATT
    CGGCGAGATC
    51 AGAAGAAAGC TTCCCGGAGC AACTCGGTCG TTGTGACTCA
    TTCCGAGTTA
    101 AAAAAAACGG GTTTTCGACA CCATGGATAT GAGTTCAATG
    GCTGGTTCAA
    151 TCGGAGTTTC GGTAGCCGTA CTCCGATTCC TCCTCTGTTT
    CGTTGCCACG
    201 ATCCCTGTTT CATTCGCTTG TCGAATCGTC CCGAGTAGAC
    TCGGTAAACA
    251 CTTGTATGCC GCTGCTTCAG GTGCTTTCCT CTCTTACCTC
    TCCTTTGGCT
    301 TCTCCTCCAA CCTTCACTTC CTTGTTCCGA TGACGATCGG
    ATATGCTTCA
    351 ATGGCGATTT ATAGACCCAA GTGTGGAATC ATCACTTTCT
    TCCTCGGTTT
    401 CGCTTATCTT ATTGGCTGTC ATGTGTTTTA TATGAGTGGT
    GATGCGTGGA
    451 AAGAAGGAGG AATCGATTCT ACTGGAGCGT TAATGGTGTT
    GACGCTGAAA
    501 GTCATCTCAT GTTCAATGAA TTACAATGAT GGGATGTTGA
    AGGAGGAAGG
    551 TCTACGTGAA GCTCAGAAGA AAAACAGATT GATTCAGATG
    CCGTCTTTGA
    601 TTGAGTACTT TGGTTACTGC CTTTGTTGTG GTAGCCATTT
    TGCTGGTCCT
    651 GTTTATGAAA TGAAAGATTA TCTTGAATGG ACCGAAGGGA
    AAGGGATTTG
    701 GGATACTACT GAGAAAAGAA AGAAGCCATC GCCTTATGGA
    GCTACAATCC
    751 GAGCTATTTT GCAAGCTGCG ATTTGCATGG CTCTGTATCT
    CTATTTAGTG
    801 CCTCAATATC CGTTAACTCG GTTCACAGAA CCAGTGTATC
    AAGAATGGGG
    851 ATTCTTGAGA AAATTTAGTT ACCAATACAT GGCTGGATTC
    ACGGCTCGTT
    901 GGAAGTATTA CTTCATCTGG TCAATTTCAG AGGCTTCTAT
    TATCATCTCT
    951 GGTTTGGGTT TCAGTGGTTG GACTGATGAT GCTTCACCAA
    AGCCCAAATG
    1001 GGACCGTGCC AAGAACGTAG ATATTCTCGG TGTTGAACTA
    GCTAAGAGCG
    1051 CGGTTCAGAT TCCACTTGTG TGGAACATAC AAGTCAGCAC
    GTGGCTCCGT
    1101 CACTATGTGT ATGAGAGACT TGTGCAGAAC GGAAAGAAAG
    CGGGTTTCTT
    1151 CCAGTTACTA GCTACACAAA CCGTCAGCGC GGTTTGGCAT
    GGACTGTATC
    1201 CTGGATATAT GATGTTCTTT GTTCAGTCAG CTTTGATGAT
    CGCAGGCTCA
    1251 CGGGTTATTT ACCGGTGGCA ACAAGCGATC AGTCCGAAAA
    TGGCAATGCT
    1301 GAGAAATATA ATGGTCTTCA TCAACTTCCT TTACACTGTT
    TTGGTTCTCA
    1351 ACTACTCAGC CGTCGGTTTC ATGGTGTTAA GCTTGCACGA
    AACACTTACC
    1401 GCCTACGGAA GCGTATATTA CATTGGAACA ATCATACCTG
    TTGGATTGAT
    1451 TCTCCTCAGT TACGTTGTGC CTGCAAAACC TTCAAGACCA
    AAACCGCGTA
    1501 AAGAAGAATA AGCAGTTATC TTCTTCTCTT AACGGTAAGT
    AAGTTTCCCG
    1551 CGCTTGCCAG CTTCTTCTTC TTCTTCTGTA ACATTTGGAA
    ACAAACCGAT
    1601 CCGGTTCTTG TTTCTCTCTG ATTTTTTAGC ACCGATATTT
    TTTTTGTATT
    1651 TGTTGCTTAT AAATCTTATT TTTCACACTT CTTTTTTTTA
    ATTAGTATTG
    1701 GATTTGCAAT TATATAGACA ATAAGTATAA ATATGTAACT
    GTAAATTGCA
    1751 AATGGGAAAA AATAGTAGTG TTTATGTTTG
  • The deduced amino acid sequence of Arabidopsis LPC acyltransferase 1 is SEQ ID NO: 4:
  • 1 MDMSSMAGSI GVSVAVLRFL LCFVATIPVS FACRIVPSRL
    GKHLYAAASG
    51 AFLSYLSFGF SSNLHFLVPM TIGYASMAIY RPKCGIITFF
    LGFAYLIGCH
    101 VFYMSGDAWK EGGIDSTGAL MVLTLKVISC SMNYNDGMLK
    EEGLREAQKK
    151 NRLIQMPSLI EYFGYCLCCG SHFAGPVYEM KDYLEWTEGK
    GIWDTTEKRK
    201 KPSPYGATIR AILQAAICMA LYLYLVPQYP LTRFTEPVYQ
    EWGFLRKFSY
    251 QYMAGFTARW KYYFIWSISE ASIIISGLGF SGWTDDASPK
    PKWDRAKNVD
    301 ILGVELAKSA VQIPLVWNIQ VSTWLRHYVY ERLVQNGKKA
    GFFQLLATQT
    351 VSAVWHGLYP GYMMFFVQSA LMIAGSRVIY RWQQAISPKM
    AMLRNIMVFI
    401 NFLYTVLVLN YSAVGFMVLS LHETLTAYGS VYYIGTIIPV
    GLILLSYVVP
    451 AKPSRPKPRK EE
  • Arabidopsis LPC acyltransferase 2
  • Nucleotide sequence of Arabidopsis LPC acyltransferase 2 cDNA is SEQ ID NO: 5:
  • 1 AGATGTCCGA ACTGTGAGAG TCGTCGTCGT CGTCGTAACT
    CAGTCCGAGT
    51 TGACACAATC TTCCACTTCA CGCAAGATAC AACCATGGAA
    TTGCTTGACA
    101 TGAACTCAAT GGCTGCCTCA ATCGGCGTCT CGGTCGCCGT
    TCTCCGTTTC
    151 CTCCTCTGTT TCGTCGCAAC GATACCAATC TCATTTTTAT
    GGCGATTCAT
    201 CCCGAGTCGA CTCGGTAAAC ACATATACTC AGCTGCTTCT
    GGAGCTTTCC
    251 TCTCTTATCT CTCCTTTGGC TTCTCCTCAA ATCTTCACTT
    CCTTGTCCCA
    301 ATGACGATTG GTTACGCTTC AATGGCGATT TATCGACCCT
    TGTCTGGATT
    351 CATTACTTTC TTCCTAGGCT TCGCTTATCT CATTGGCTGT
    CATGTGTTTT
    401 ATATGAGTGG TGATGCTTGG AAAGAAGGAG GAATTGATTC
    TACTGGAGCT
    451 TTGATGGTAT TAACACTGAA AGTGATTTCG TGTTCGATAA
    ACTACAACGA
    501 TGGAATGTTG AAAGAAGAAG GTCTACGTGA GGCTCAGAAG
    AAGAACCGTT
    551 TGATTCAGAT GGCTTCTCTT ATTGAGTACT TTGGTTATTG
    CCTCTGTTGT
    601 GGAAGCCATT TGGCTGGCCC GGTTTTCGAA ATGAAAGATT
    ATCTCGAATG
    651 GACTGAAGAG AAAGGAATTT GGGCTGTTTC TGAAAAAGGA
    AAGAGACCAT
    701 CGCCTTATGG AGCAATGATT CGAGCTGTGT TTCAAGCTGC
    GATTTGTATG
    751 GCTCTCTATC TCTATTTAGT ACCTCAGTTT CCGTTAACTC
    GGTTCACTGA
    801 ACCAGTGTAC CAAGAATGGG GATTCTTGAA GAGATTTGGT
    TACCAATACA
    851 TGGCGGGTTT CACGGCTCGT TGGAAGTATT ACTTTATATG
    GTCTATCTCA
    901 GAGGCTTCTA TTATTATCTC TGGTTTGGGT TTCAGTGGTT
    GGACTGATGA
    951 AACTCAGACA AAGGCTAAAT GGGACCGCGC TAAGAATGTC
    GATATTTTGG
    1001 GGGTTGAGCT TGCCAAGAGT GCGGTTCAGA TTCCGCTTTT
    CTGGAACATA
    1051 CAAGTCAGCA CATGGCTCCG TCACTACGTA TATGAGAGAA
    TTGTGAAGCC
    1101 CGGGAAGAAA GCGGGTTTCT TCCAATTGCT AGCTACGCAA
    ACCGTCAGTG
    1151 CTGTGTGGCA TGGACTGTAT CCTGGATACA TTATATTCTT
    TGTGCAATCA
    1201 GCATTGATGA TCGATGGTTC GAAAGCTATT TACCGGTGGC
    AACAAGCAAT
    1251 ACCTCCGAAA ATGGCAATGC TGAGAAATGT TTTGGTTCTC
    ATCAATTTCC
    1301 TCTACACAGT AGTGGTTCTC AATTACTCAT CCGTCGGTTT
    CATGGTTTTA
    1351 AGCTTGCACG AAACACTAGT CGCCTTCAAG AGTGTATATT
    ACATTGGAAC
    1401 AGTTATACCT ATCGCTGTGC TTCTTCTCAG CTACTTAGTT
    CCTGTGAAGC
    1451 CTGTTAGACC AAAGACCAGA AAAGAAGAAT AATGTTGTCT
    TTTTAAAAAA
    1501 TCAACAACAT TTTGGTTCTT TTCTTTTTTT CCACTTGGAC
    CGTTTTATGT
    1551 AAAACAAGAG AAATCAAGAT TTGAGGTTTT ATTCTTCTTC
    TCCTTCCCAA
    1601 TTTTCGAAAA TGATTTTATT TTTTCTGATA TATATCTAAG
    CTAGTCCAAA
    1651 GTCAACTCG
  • The deduced amino acid sequence of Arabidopsis LPC acyltransferase 2 is SEQ ID NO: 6:
  • 1 MELLDMNSMA ASIGVSVAVL RFLLCFVATI PISFLWRFIP
    SRLGKHIYSA
    51 ASGAFLSYLS FGFSSNLHFL VPMTIGYASM AIYRPLSGFI
    TFFLGFAYLI
    101 GCHVFYMSGD AWKEGGIDST GALMVLTLKV ISCSINYNDG
    MLKEEGLREA
    151 QKKNRLIQMP SLIEYFGYCL CCGSHFAGPV FEMKDYLEWT
    EEKGIWAVSE
    201 KGKRPSPYGA MIRAVFQAAI CMALYLYLVP QFPLTRFTEP
    VYQEWGFLKR
    251 FGYQYMAGFT ARWKYYFIWS ISEASIIISG LGFSGWTDET
    QTKAKWDRAK
    301 NVDILGVELA KSAVQIPLFW NIQVSTWLRH YVYERIVKPG
    KKAGFFQLLA
    351 TQTVSAVWHG LYPGYIIFFV QSALMIDGSK AIYRWQQAIP
    PKMAMLRNVL
    401 VLINFLYTVV VLNYSSVGFM VLSLHETLVA FKSVYYIGTV
    IPIAVLLLSY
    451 LVPVKPVRPK TRKEE
  • EXAMPLE 3 Transformation of a Plant with LPC Acyltransferase Gene
  • Transformation protocol is adapted from that described by Bechtold et al. (1993). Plants are grown in moist soil at a density of 10-12 plants per pot, in 4-inch square pots, and are covered with a nylon screen fixed in place with an elastic band. When the plants reach the stage at which bolts emerge, plants are watered, the bolts and some of the leaves are clipped, and the plants are infiltrated in Agrobacterium suspension as outlined below.
  • Agrobacterium transformed with the LPC acyltransferase gene of the instant invention is grown in a 25 mL suspension in LB medium containing kanamycin at a concentration of 50 μg/mL. The Agrobacterium is cultured for two to three days. The day before infiltration, this “seed culture” is added to 400 mL of LB medium containing 50 μglmL kanamycin. When the absorbance at 600 nm is >2.0, the cells are harvested by centrifugation (5,000 times g, 10 min in a GSA rotor at room temperature) and are re-suspended in 3 volumes of infiltration medium (1/times Murashige and Skoog salts, 1 times. B5 vitamins, 5.0% sucrose, 0.044 μM benzylaminopurine) to an optical density at 600 nm of 0.8. The Agrobacterium suspension is poured into a beaker and the potted plants are inverted into the beaker so that the bolts and entire rosettes are submerged. The beaker is placed into a large Bell jar and a vacuum is drawn using a vacuum pump, until bubbles form on the leaf and stem surfaces and the solution starts to bubble a bit, and the vacuum is rapidly released. The necessary time and pressure vanes from one lab setup to the next; but good infiltration is visibly apparent as uniformly darkened, water-soaked tissue. Pots are removed from the beaker, are laid on their side in a plastic tray and are covered with a plastic dome, to maintain humidity. The following day, the plants are uncovered, set upright and are allowed to grow for approximately four weeks in a growth chamber under continuous light conditions as described by Katavic et al., (1995). When the siliques are mature and dry, seeds are harvested and selected for positive transformants.
  • EXAMPLE 4 Selection of Putative Transformants (Transgenic Plants) and Growth and Analysis of Transgenic Plants
  • Seeds are harvested from vacuum-infiltration transformation procedures, and are sterilized by treating for 1 min in ethanol and 5 min in. 50% bleach/0.05% Tween™ 20™ in sterile distilled water. The seeds are rinsed several times with sterile distilled water. Seeds are plated by re-suspending them in sterile 0.1% agarose at room temperature (about 1 mL agarose for every 500-1000 seeds), and applying a volume equivalent to about 2,000-4,000 seeds onto 150×15 mm selection plates (1/2×Murashige and Skoog salts, 0.8% agar, autoclave, cool and add 1×B5 vitamins and kanamycin at a final concentration of 50 μg/mL). The plates are dried in a laminar flow hood until seed no longer flows when the plates are tipped. The plates are vernalized for two nights at 4° C. in the dark, and are moved to a growth chamber (conditions as described by Katavic et al., 1995). After 7-10 days, transformants are clearly identifiable as dark green plants with healthy green secondary leaves and roots that extend over and into the selective medium.
  • Seedlings are transplanted to soil, plants are grown to maturity and mature seeds (T2 generation as defined in Katavic et al., 1994) are collected and analyzed. T2 seeds are propagated. The vegetative growth patterns are monitored by measuring shoot tissue dry weights, and/or by counting the number of rosette leaves present by the time plants began to enter the generative (flower initiation) stage. Floral initiation (beginning of generative phase of growth) is analyzed by recording, on a daily basis, the percentage of plants in which a flower bud first appears and/or the percentage of plants that are bolting (as described by Zhang et al. 1997). Data is reported in terms of percentage of plants flowering/bolting on a given day after planting (d.a.p.).
  • EXAMPLE 5 Analysis of Fatty Acids
  • Cells or plants transformed with the LPC acyltransferase gene of the instant invention are grown to maturity and mature seeds are harvested. Fatty acids are extracted from the cells or plants transformed with the LPC acyltransferase gene. Normal-phase HPLC analysis is used to assay for the production of fatty acids in the transformed cells or plants.
  • EXAMPLE 6 Analysis of LPCAT from Various Species
  • (1) Identification of LPCAT from the alga Thalassiosira pseudonana
  • We made use of the sequence information of LPCAT from S. cerevisiae (SEQ ID NO: 1) and identified a sequence coding for LPCAT from the alga T. pseudonana. This algal LPCAT shows 27% identity at the amino acid to the yeast LPCAT which is encoded by YOR175c.
  • The nucleotide and amino acid sequences of LPCAT from T. pseudonana
  • a. The nucleotide sequence of LPCAT from the alga T. pseudonana
  • (SEQ ID NO: 7)
             ATGCGATTGTATTTGCAATTCAACTTATCCATCAATGATTA
    TTGTCACTTCTTCACAGTACCATCCTTTGTCAAAGAGGGCGTCGAGTCTC
    TCTCTGCATCCACCGGACAAGACGTCGAGACTCTCGAGTACCTCCTTGGT
    ATGCTCATCTGCTACCCCCTCGGAATGATCATGCTCGCTCTACCCTACGG
    AAAAGTAAAACATCTCTTCTCCTTCATCCTCGGAGCCTTCCTACTTCAAT
    TCACCATTGGTATCCAGTGGATTCATCACTTAATCTCCTCAATGATTGCC
    TACGTCATGTTCCTCGTCCTTCCTGCCAAATTTGCCAAAACGGCAGTGCC
    TGTGTTTGCCATGATCTACATCACCGCGGGACATTTGCATCGTCAATACA
    TCAATTATCTTGGGTGGGATATGGACTTCACGGGGCCTCAGATGGTGCTT
    ACGATGAAACTCTACATGCTTGCTTACAACCTTGCGGATGGGGACTTGCT
    CAAGAAGGGAAAGGAGGATAGGGCTGCAAAGAAGTGTGCGGATGTCGCTA
    TTTCGTCTGTTCCCGGAATCATTGAGTACTTGGGCTACACGTTCTGCTTT
    GCCAGTGTTTTAGCAGGCCCTGCTTTTGAGTACAAATTCTACGCCGATGC
    ATGCGACGGATCACTCTTGTACGACAAATCTGGCAAACCCAAAGGAAAGA
    TCCCCAGTCAGGTGTGGCCTACATTGCGTCCTCTTTTTGGAAGTCTCTTG
    TGTCTCGGCATCTTTGTTGTGGGAACTGGAATGTATCCTCTTTTGGATCC
    CAACGATCCTCAGAATGCCACTCCTATCCCTCTCACTCCAGAGATGTTGG
    CCAAACCAGCCTATGCTCGATACGCTTACTCGTGGCTTGCACTCTTTTTC
    ATCCGATTTAAGTATTACTTTGCTTGGATGAACGCCGAAGGAGCAAGCAA
    CATTTGGTATGCTGGATTTGAGGGATTTGATGCCAGCGGCAACCCCAAAG
    GATGGGAGGTATCCAATAACATTGACGTAATTCAGTTCGAGACTGCACCC
    AATCTCAAGACTTTGAGTGCTGCTTGGAATAAGAAGACTGCGAACTGGTT
    GGCGAAGTATGTGTACATTCGCACGGGTGGTTCTCTCTTTGCGACGTACG
    GAATGAGTGCTTTCTGGCATGGCTTCTACCCTGGATACTACCTCTTCTTC
    ATGTCGGTACCCATGATGGCTTTCTGTGAGAGGATTGGAAGGAAGAAACT
    TACACCTCGTTTCGGAAATGGAAAGAAGTGGAGTCCTTATGGCATTGTGT
    GCATTATCGCCACATCGTTGATGACGGAATACATGATTCAGCCATTCCAA
    CTACTTGCGTTTGATTGGGCCTGGGAGAACTGGAGCAGCTACTACTTTGC
    TGGACACATTGTTTGTGTTGTGTTTTACCTCGTTGTGTCCAACATGCCTA
    CACCAAAGACGAAGGAGACTTAA
  • b. The amino acid sequence of LPCAT from T. pseudonana
  • (SEQ ID NO: 8)
    MRLYLQFNLSINDYCHFFTVPSFVKEGVESLSASTGQDVETLEYLLGMLI
    CYPLGMIMLALPYGKVKHLFSFILGAFLLQFTIGIQWIHHLISSMIAYVM
    FLVLPAKFAKTAVPVFAMIYITAGHLHRQYINYLGWDMDFTGPQMVLTMK
    LYMLAYNLADGDLLKKGKEDRAAKKCADVAISSVPGIIEYLGYTFCFASV
    LAGPAFEYKFYADACDGSLLYDKSGKPKGKIPSQVWPTLRPLFGSLLCLG
    IFVVGTGMYPLLDPNDPQNATPIPLTPEMLAKPAYARYAYSWLALFFIRF
    KYYFAWMNAEGASNIWYAGFEGFDASGNPKGWEVSNNIDVIQFETAPNLK
    TLSAAWNKKTANWLAKYVYIRTGGSLFATYGMSAFWHGFYPGYYLFFMSV
    PMMAFCERIGRKKLTPRFGNGKKWSPYGIVCIIATSLMTEYMIQPFQLLA
    FDWAWENWSSYYFAGHIVCVVFYLVVSNMPTPKTKET
  • (2) Identification of LPCAT from diverse plant species
  • Taking the same approach as described above, identified were the full-length or partial sequences of LPCAT from various plant species, including apple, barley, Capsicum annuum, castor bean, grapevine, maize, peach, rice, tomato, snapdragon, sorghum, sunflower, vaccinium corymbosum and wheat as well as Arabidopsis.
  • (1) The partial nucleotide sequence of LPCAT from apple
  • (SEQ ID NO: 9)
            TCAGGAGGCCCAAATTTCCTTTGTCAAGATTTACTGAGCCCA
    TATACCAAGAATGGGGGTTTTGGAAACGACTTTTCTACCAGTATATGTCT
    GGATTCACAGCAAGGTGGAAATATTATTTCATTTGGTCAATATCAGAGGC
    TTCTATCATTCTTTCTGGCCTCGGTTTCAGTGGCTGGACAGAGTCCTCAC
    CACCAAAACCTCGATGGGATCGTGCAAAAAATGTTGATATTATAGGCGTT
    GAGTTTGCAAAGAGTTCAGTTCAGTTACCACTTGTTTGGAACATACAAGT
    CAGCACCTGGCTTCGCCATTATGTTTATGATAGGCTTGTTAAACCTGGAA
    AGAAGCCTGGTTTCTTCCAGTTGCTGGCTACACAGACCGTCAGTGCTGTT
    TGGCATGGCCTCTATCCTGGCTACATCATATTCTTTGTTCAGTCAGCGTT
    GATGATTGCTGGATCAAGAGTGATTTACCGATGGCAGCAAGCTGTACCTC
    CAACTATGGATGTTGTTAAGAAGATATTGGTGTTCATCAACTTTGCTTAC
    ACTGTCTTGGTTCTGAACTACTCCTGTGTTGGTTTCATTGTATTAAGCCT
    TCGTGAAACACTGGCCTCGTATGGAAGCGTGCATTTC
  • The partial amino acid sequence of LPCAT from apple
  • (SEQ ID NO: 10)
              RRPKFPLSRFTEPIYQEWGFWKRLFYQYMSGFTARWKYYF
    IWSISEASIILSGLGFSGWTESSPPKPRWDRAKNVDIIGVEFAKSSVQLP
    LVWNIQVSTWLRHYVYDRLVKPGKKPGFFQLLATQTVSAVWHGLYPGYII
    FFVQSALMIAGSRVIYRWQQAVPPTMDVVKKILVFINFAYTVLVLNYSCV
    GFIVLSLRETLASYGSVHF
  • (2) The partial amino acid sequence of LPCAT from barley
  • (SEQ ID NO: 11)
            EAAIIISGLGFTGWSDSSPPKAKWDRAINVDILGVELAGSAA
    QLPLKWNIQVSTWLRYYVYERLIQKGKKPGFLQLLGTQTVSAIWHGLYPG
    YMIFFVQSALMINGSKVIYRWQQAVKQFRPPHYPVFTKLLHTP
  • (3) The partial nucleotide sequence of LPCAT from Capsicum annuum
  • (SEQ ID NO: 12)
              GGCACGAGAAACGGTTGGGTTACCAATATATGGCTGGCTT
    TACTGCCCGGTGGAAGTATTATTTTATCTGGTCAATCTCTGAAGCTGCTA
    TAATCATATCTGGACTGGGTTTCAGTGGTTGGACAGACTCTTCTCCGCCA
    AAACCACGTTGGGACCGTGCAAAAAATGTTGATGTATTGGGTGTTGAGTT
    AGCAAAGAGCTCGGTTCAGTTGCCTGCTGTCTGGAACATTCAAGTCAGCA
    CATGGCTGCGGCATTATGTATATGAAAGGCTCATACAAAAGGGAAGGAAG
    CCTGGTTTCTTCCAGTTACTGGCTACCCAAACTGTCAGTGCCGTATGGCA
    TGGATTATATCCTGGGTATATCATATTCTTTGTACAGTCCGCTTTGATGA
    TTGCTGGATCAAGAGTCCTTTACAGATGGCAGCAAGCTGCTAAAGGTTCT
    ATGTTTGAGAAGATACTGGTAGCAATGAATTTTGCATACACACTGCTGGT
    TCTAAATTACTCCGCTGTTGGGTTCATGGTATTAAGCCTGCATGAAACTC
    TTACTGCTTATGGAAGTGTATACTATGTTGGAACAATTATACCAATTGCT
    CTCATCCTGCTCAGTAAAGTAATTAAGCCTCCAAGACCCTGCACATCTAA
    AG
  • The partial amino acid sequence of LPCAT from Capsicum annuum
  • (SEQ ID NO: 13)
            HEKRLGYQYMAGFTARWKYYFIWSISEAAIIISGLGFSGWTD
    SSPPKPRWDRAKNVDVLGVELAKSSVQLPAVWNIQVSTWLRHYVYERLIQ
    KGRKPGFFQLLATQTVSAVWHGLYPGYIIFFVQSALMIAGSRVLYRWQQA
    AKGSMFEKILVAMNFAYTLLVLNYSAVGFMVLSLHETLTAYGSVYYVGTI
    IPIALILLSKVIKPPRPCTSK
  • (4) The partial nucleotide sequence of LPCAT from castor bean
  • (SEQ ID NO: 14)
            ATTCATTTATACTTGGTGCCCCACTATCCTTTATCCCGGTTC
    ACTGATCCTGTGTACCAAGAATGGGGCTTCTGGAAACGATTAACTTATCA
    GTATATGTCAGGTTTAACAGCACGTTGGAAATACTACTTCATCTGGTCAA
    TTTCCGAGGCCTCCATTATTATCTCTGGATTGGGTTTCAGTGGTTGGACA
    GATACTTCTCCACCAAAGCCACAGTGGGATCGCGCTAGAAACGTTGACAT
    TCTAGGTGTTGAGTTTGCAAAGAGTGCAGCTGAGTTGCCACTTGTGTGGA
    ACATACAAGTCAGCACATGGCTTCGCCACTATGTTTATGATCGACTTGTT
    CCAAAGGGAAAGAAAGCTGGTTTCGTTCAGTTGTTGGCCACTCAGACTAC
    CAGTGCTGTTTGGCATGGATTATATCCTGGATACATTATATTCTTTGTCC
    AGTCAGCATTAATGATTGCAGGTTCGAAAGTCATATACAGATGGCAACAA
    GCTATACCTTCAAATAAGGCTCTTGAAAAGAAGATACTAGTGTTTATGAA
    CTTTGCTTACACAGTTTTGGTTCTAAATTACTCCTGTGTTGGTTTCATGG
    TTTTAAGCTTGCATGAAACGATTGCAGCATATGGAAGTGTATATTTTATT
    GGCACCATAGTGCCCGTTGTATTTTTCCTCCTTGGCTTCATTATTAAACC
    AGCAAGGCCTTCCAGGTCTAAACACGGAACGATGAGTGAGGTAGAAACTG
    TTTTTCTTCTCCTT
  • The partial amino acid sequence of LPCAT from castor bean
  • (SEQ ID NO: 15)
            IHLYLVPHYPLSRFTDPVYQEWGFWKRLTYQYMSGLTARWKY
    YFIWSISEASIIISGLGFSGWTDTSPPKPQWDRARNVDILGVEFAKSAAE
    LPLVWNIQVSTWLRHYVYDRLVPKGKKAGFLQLLATQTTSAVWHGLYPGY
    IIFFVQSALMIAGSKVIYRWQQAIPSNKALEKKILVFMNFAYTVLVLNYS
    CVGFMVLSLHETIAAYGSVYFIGTIVPVVFFLLGFIIKPARPSRSKHGTM
    SEVETVFLLL
  • (5) The partial nucleotide sequence of LPCAT from grapevine
  • (SEQ ID NO: 16)
            CTCGTCCAATCTCCACTTCCTCGTTCCCATGCTTCTTGGCTA
    CGCGGCTATGCTTCTCTGTCGCCGTCGATGCGGTGTGATCACCTTTTTCT
    TGGGATTCGGCTACCTCATTGGCTGCCATGTATACTACATGAGTGGGGAT
    GCATGGAAGGAAGGGGGTATTGATGCTACTGGAGCTCTAATGGTTTTAAC
    ATTGAAAGTCATTTCATGTGCAATGAATTATAATGATGGATTGTTAAAAG
    AAGACGGTTTGCGTGAGGCACAGAAGAAAAACCGATTGCTTAAGTTACCA
    TCATTGATCGAGTACTTTGGTTATTGTCTCTGCTGTGGAAGTCACTTTGC
    TGGACCAGTTTATGAAATAAAGGATTATCTTGAATGGACAGAAAGAAAAG
    GGATTTGGGCCAAATCAGAGAAAGGGCCACCACCATCACCTTATGGGGCA
    ACGATTCGAGCTCTTATCCAAGCTGCCTTTTGCATGGGCTTGTATGTGTA
    TCTAGTACCCCATTTTCCCTTGACCATATTTACTGATCCTGTATATCAAG
    AATGGGGCTTCTGGAAACGGTTGGGATACCAATATATGTGTGGCTTTACA
    GCACGCTGGAAATACTATTTCATCTGGTCAATCTCTGAGGCAGCTGTCAT
    TATTTCTGGCCTGGGATTCAGTGGGTGGACAGAATCTTCCCCACCAAAAC
    CAAAATGGGACCGTGCAAAGAATGTTGACATTTTAGGTGTTGAGTTGGCA
    AAGAGTGCAGTAACACTGCCACTTGTTTGGAACATACAAGTCAGCACCTG
    GCTACGTTATTATGTTTATGAGAGGCTCATTCAAAATGGGAAGAAACCTG
    GTTTCTTCCAGTTGCTGGCTACACAAACTGTCAGTGCTGTTTGGCATGGA
    TTATATCCTGGATACATCATATTCTTTGTTCAGTCTGCACTGATG
  • The partial amino acid sequence of LPCAT from grapevine
  • (SEQ ID NO: 17)
    SSNLHFLVPMLLGYAAMLLCRRRCGVITFFLGFGYLIGCHVYYMSGDAWK
    EGGIDATGALMVLTLKVISCAMNYNDGLLKEDGLREAQKKNRLLKLPSLI
    EYFGYCLCCGSHFAGPVYEIKDYLEWTERKGIWAKSEKGPPPSPYGATIR
    ALIQAAFCMGLYVYLVPHFPLTIFTDPVYQEWGFWKRLGYQYMCGFTARW
    KYYFIWSISEAAVIISGLGFSGWTESSPPKPKWDRAKNVDILGVELAKSA
    VTLPLVWNIQVSTWLRYYVYERLIQNGKKPGFFQLLATQTVSAVWHGLYP
    GYIIFFVQSALM
  • (6) The partial nucleotide sequence of LPCAT from maize
  • (SEQ ID NO: 18)
    CATTTCGTGTCTCATAAACTACAGTGATGGTATCTTGAAGGAAGAGGGTT
    TACGCGATGCTCAGATTAAACACCGATTGACTAAGCTTCCTTCTCTAATT
    GAATATTTTGGGTACTGTCTCTGTTGTGGGAGCCACTTTGCTGGACCGGT
    ATATGAGATGAAAGATTATCTTGAATGGACTGAAAGGAAAGGAATATGGG
    CTAGCCCAACTCCTTCGCCATTGTTACCTACTTTGCGTGCTCTAGTTCAG
    GCTGGTATATGCATGGGGTTATATTTATACCTGTCACCTAAATTTCCACT
    CTCACGGTTTAGTGAGCCCCTATATTATGAATGGGGTTTTTGGCACCGAC
    TCTTCTATCAGTACATGTCAGGCTTTACCGGTCGTTGGAAATATTACTTT
    ATATGGTCAATTTCAGAAGCCTCAATTATCATATCTGGTCTAGGCTTTAC
    TGGTTGGTCGGAATCTTCTCCCCCAAAAGCCAAATGGGATCGTGCAAAAA
    ATGTTGATGTATTAGGTGTTGAATTAGCTGGAAGTTCAGTTGAATTGCCC
    CTTGTGTGGAATATTCAAGTGAGCACATGGCTACGATACTATGTCTATGA
    GAGGTTAATTCAGAAAGGAAAGAAACCAGGTTTCCTTCAATTGTTGGGTA
    CACAGACAGTCAGTGCCATCTGGCATGGACTATATCCTGGATATATCATA
    TTCTTTTTTTCATCAGCATTGATGATNAATGGTTCACGAGTTATATACAG
    ATGGCAGCAAGCAGCGAGCAGTTCATTCCTGAGCGGTATCCTGGCCCTTC
    TAATTTTGCTATACATTGCTGGGGCTTACTACTCCTGCATCGGGGTCCAG
    GTACTGAGCTTCAA
  • The partial amino acid sequence of LPCAT from maize
  • (SEQ ID NO: 19)
    ISCLINYSDGILKEEGLRDAQIKHRLTKLPSLIEYFGYCLCCGSHFAGPV
    YEMKDYLEWTERKGIWASPTPSPLLPTLRALVQAGICMGLYLYLSPKFPL
    SRFSEPLYYEWGFWHRLFYQYMSGFTARWKYYFIWSISEASIIISGLGFT
    GWSESSPPKAKWDRAKNVDVLGVELAGSSVQLPLVWNIQVSTWLRYYVYE
    RLIQKGKKPGFLQLLGTQTVSAIWHGLYPGYIIFFFSSALMXNGSRVIYR
    WQQAASSSFLSGILALLILLYIAGAYYSCIGVQVLSF
  • (7) The partial nucleotide sequence of LPCAT from peach
  • (SEQ ID NO: 20)
    AAATATTATTTCATCTGGTCAATTTCAGAGGCTTCTATCATTCTTTCTGG
    TTTGGGTTTCACTGGCTGGACAGAATCTTCACCACCAAAGCCGCGATGGG
    ATCGTGCAAAAAATGTTGATATTCTAGGCGTTGAGTTTGCAAAGAGTTCA
    GTTCAGTTACCACTTGTTTGGAACATACAAGTCAGCACCTGGCTACGTCA
    TTATGTTTATGAAAGGCTTGTTAAACCTGGCAAGAAGGCTGGTTTCTTCC
    AGTTGCTGACTACACAGACCGTCAGTGCGGTTTGGCATGGACTCTATCCT
    GGGTACATCATATTCTTTGTTCAGTCAGCATTGATGATTGCTGGTTCAAG
    AGTGATTTACAGATGGCAACAAGCTGTACCTCAAAACATGGATGCTGTTA
    AGAACATACTGGTGTTCATAAACTTTGCTTACACTCTCTTGGTTCTGAAC
    TACTCCTGCGTTGGTTTCATTGTATTAAGCCTTCGTGAAACACTTGCCTC
    ATATGGGAGCGTGCATTTCATCGGAACCATTCTTCCGATAGCATTGATAC
    TACTGAGTTACGTAATAAAACCTCCAAGGCCTGCAAGATCAAAGGCTCGG
    AAGGAAGAGTGAGGTTGTCANCCGCAACAGCATTTTTAACG
  • The partial amino acid sequence of LPCAT from peach
  • (SEQ ID NO: 21)
    KYYFIWSISEASIILSGLGFTGWTESSPPKPRWDRAKNVDILGVEFAKSS
    VQLPLVWNIQVSTWLRHYVYERLVKPGKKAGFFQLLTTQTVSAVWHGLYP
    GYIIFFVQSALMIAGSRVIYRWQQAVPQNMDAVKNILVFINFAYTLLVLN
    YSCVGFIVLSLRETLASYGSVHFIGTILPIALILLSYVIKPPRPARSKAR
    KEE
  • (8) The full-length or partial amino acid sequence of LPCAT from rice
  • Sequence 1 (accession number Os02g0676000
    (SEQ ID NO: 22))
    MGLEMEGMAAAIGVSVPVLRFLLCFAATIPTGLMWRAVPGAAGRHLYAGL
    TGAALSYLSFGATSNLLFVVPMAFGYLAMLLCRRLAGLVTFLGAFGFLIA
    CHMYYMSGDAWKEGGIDATGALMVLTLKIISCAINYSDGMLKEEGLRDAQ
    KKYRLAKLPSLIEYFGYCLCCGSHFAGPVYEMKDYLEYTERKGLWASPTP
    SPLLPTLRALVQAGACMGLYLYLSPQFPLSRFSEPLYYEWGFWHRLFYQY
    MSGFTARWKYYFIWSLSEAAIIISGLGFSGWSDSSPPKAKWDRAKNVDVL
    GVELATSAVQLPLMWNIQVSTWLRYYVYERLVQKGKKPGFLQLLGTQTVS
    AVWHGLYPGYIIFFVQSALMINGSKVIYRWQQAVSNPVFHAILVFVNFSY
    TLMVLNYSCIGFQVLSFKETLASYQSVYYIGTIVPIVVVLLGYVIKPARP
    VKPKARKAE
    Sequence 2 (accession number EAY87053
    (SEQ ID NO: 23))
    MYYMSGDAWKEGGIDATGALMVLTLKIISCAINYSDGMLKEEGLRDAQKK
    YRLAKLPSLIEYFGYCLCCGSHFAGPVYEMKDYLEYTERKGLWASPTPSP
    LLPTLRALVQAGACMGLYLYLSPQFPLSRFSEPLYYEWGFWHRLFYQYMS
    GFTARWKYYFIWSLSEAAIIISGLGFSGWSDSSPPKAKWDRAKNVDVLGV
    ELATSAVQLPLMWNIQVSTWLRYYVYERLVQKGKKPGFLQLLGTQTVSAV
    WHGLYPGYIIFFVQSALMINGSKVIYRWQQAVSNPVFHAILVFVNFSYTL
    MVLNYSCIGFQFVFTMLYTLRFLQVLSFKETLASYQSVYYIGTIVPIVVV
    LLGYVIKPARPVKPKARKAE
  • (9) The partial nucleotide sequence of LPCAT from snapdragon
  • (SEQ ID NO: 24)
    GCATTAATTACAACGATGGATTACTTAAAAAGGAAGATCTACGTGAGCCA
    CAAAAGAAAAACCGCTTGCTCAAGATGCCATCATTACTTGAGTACATTGG
    TTACTGTTTGTGTTGTGGAAGTCACTTTGCTGGTCCTGTGTATGAAATGA
    AAGATTATCTTGAATGGACTGAGAGGAAAGGGATCTGGCAACATACAACC
    AAGGGACCGAAACCTTCTCCGTATTGGGCGACTCTCAGGGCTATTTTGCA
    AGCTGCCATCTGTATGGGCTTGTATCTATATCTTGTACCACATTACCCAC
    TTTCCAGATTCACGGAGCCAGAATACCAAGAGTATGGGTTCTGGAAACGG
    TTAAGTTACCAGTACATGTCAGGCTTCACCGCTCGTTGGAAGTACTATTT
    CATTTGGTCTATCTCAGAAGCTTCCATAATTATTTCTGGCCTGGGGTTCA
    GTGGCTGGACAGATTCTGATCCACCCAAAGCACTGTGGGATCGTGCAAAA
    AATGTTGATGTATTAGGTGTTGAGTTGGCAAAGAGTTCTGTGCAGTTACC
    ACTTGTATGGAATATTCAAGTTAGCACCTGGCTTAAACACTATGTCTATG
    AGAGGCTGGTTCAGAAAGGTAAGAAACCAGGCTTCTTCCAGTTGCTGGCT
    ACCCAGACCGTGAGTGCAGTGTGGCATGGATTGTACCCTGGGTACATCAT
    ATTCTTT
  • The partial amino acid sequence of LPCAT from snapdragon
  • (SEQ ID NO: 25)
    INYNDGLLKKEDLREPQKKNRLLKMPSLLEYIGYCLCCGSHFAGPVYEMK
    DYLEWTERKGIWQHTTKGPKPSPYWATLRAILQAAICMGLYLYLVPHYPL
    SRFTEPEYQEYGFWKRLSYQYMSGFTARWKYYFIWSISEASIIISGLGFS
    GWTDSDPPKALWDRAKNVDVLGVELAKSSVQLPLVWNIQVSTWLKHYVYE
    RLVQKGKKPGFFQLLATQTVSAVWHGLYPGYIIFF
  • (10) The partial nucleotide sequence of LPCAT from sorghum
  • (SEQ ID NO: 26)
    GCACGAGGCTCTCACGGTTTAGTGAGCCCTTATATTATGAATGGGGTTTC
    TGGCACCGACTCTTCTATCAGTACATGTCAGGCTTCACTGCTCGTTGGAA
    ATATTACTTTATATGGTCAATTTCAGAAGCCTCAATTATCATATCTGGTC
    TGGGCTTTACTGGTTGGTCAGAATCTTCTCCCCCGAAAGCCAAATGGGAT
    CGTGCGAAAAATGTTGATGTATTAGGTGTTGAATTAGCTGGAAGTGCAGT
    TCAAATTCCCCTTGTGTGGAATATTCAAGTGAGCACATGGTTACGATACT
    ATGTCTATGAGAGGCTAATTCAGAAAGGAAAGAAACCAGGTTTCCTTCAG
    TTGTTGGGTACACAGACAGTCAGCGCCATCTGGCATGGACTGTATCCTGG
    ATATATCATATTCTTTGTTCAGTCAGCATTGATGATAAATGGTTCACGAG
    TTATATACAGATGGCAGCAAGCAGTGAGCAGTTCATTCCTCCGCGGTATC
    CTGGCTTTTCTAAATTTTGCTTATACATTGCTGGTGCTTAACTACTCCTG
    CATCGGGTTCCTGGTACTGAGCTTCAAAGAAACCTTGGCGTCCTACCAGA
    GCGTATATTATGTTGGCACAATTGTTCCCATTGTGTTTCTCCTGCTGGGC
    AAT
  • The partial amino acid sequence of LPCAT from sorghum
  • (SEQ ID NO: 27)
    TRLSRFSEPLYYEWGFWHRLFYQYMSGFTARWKYYFIWSISEASIIISGL
    GFTGWSESSPPKAKWDRAKNVDVLGVELAGSAVQIPLVWNIQVSTWLRYY
    VYERLIQKGKKPGFLQLLGTQTVSAIWHGLYPGYIIFFVQSALMINGSRV
    IYRWQQAVSSSFLRGILAFLNFAYTLLVLNYSGIGFLVLSFKETLASYQS
    VYYVGTIVPIVFLLLGN
  • (11) The partial nucleotide sequence of LPCAT from sunflower
  • (SEQ ID NO: 28)
    GAAAACCGCATACTTAAGTTGCCATCTTTAATCGAGTATGTGGGATATTG
    CTTATGCTGCGGAAGTCACTTTGCTGGTCCGGTTTACGAAATCAAAGATT
    ATTTGGATTGGACCGAAAGAAAGGGGATTTGGACAAAGTCCGAGAAAGGC
    ACACCATCACCATTTTTGCCAACACTACGAGCGATTCTCCAAGCGGGTTT
    CTGTATGGGTTTGTATTTATATCTATCGCCTTCGTATCCGCTTTCAAGAT
    TCAGTGAGCCGATATATCAAGAATGGGGATTTGTGAAACGTCTGACCGTC
    CAATACATGTCGGGCTTCACCGCGCGTTGGAAATACTATTTCATTTGGTC
    TATCTCAGAAGCTTCTATCATTATTTCGGGCTTCGGTTTCAGTGGCTGGA
    CTGATTCTTCTCCACCAAAAGCCCGATGGGACCGTGCGAAAAACGTTGAC
    GTTTTGGGTGTTGAGTTTGCAAAGAGTTCAGTTGAGTTACCACTCGTGTG
    GAATATCCAAGTCAGCACATGGCTTCGTCACTATGTTTATGACAGACTTG
    TTCAAAAGGGAAAGAAGCCTGGCTTTTTCCAATTGTTAGCAACACAGACT
    GTTAGCGCTGTCTGGCATGGATTATATCCTGGGTACTTGATATTCTTTGT
    TCAATCTGCTTTGATGATTTCCGGGTCAAGAGCCATTTACAGATGGCAGC
    AGGCGGTTCCGCCAACCGTTAAGAAGTTTTTGATGCTCATGAACTTTGCT
    TACACGCTTCTTGTTCTTAACTACTCCTGCATAGGTTTTATGGTATTAAG
    CCTACACGAAACACTGGCTGCATACGGAAGTGTATACTACGTTGGAAACA
    TCATTCCAGTGGCGT
  • The partial amino acid sequence of LPCAT from sunflower
  • (SEQ ID NO: 29)
             ENRILKLPSLIEYVGYCLCCGSHFAGPVYEIKDYLDWTERK
    GIWTKSEKGTPSPFLPTLRAILQAGFCMGLYLYLSPSYPLSRFSEPIYQE
    WGFVKRLTVQYMSGFTARWKYYFIWSISEASIIISGFGFSGWTDSSPPKA
    RWDRAKNVDVLGVEFAKSSVELPLVWNIQVSTWLRHYVYDRLVQKGKKPG
    FFQLLATQTVSAVWHGLYPGYLIFFVQSALMISGSRAIYRWQQAVPPTVK
    KFLMLMNFAYTLLVLNYSCIGFMVLSLHETLAAYGSVYYVGNIIPVA
  • (12) The partial nucleotide sequence of LPCAT from tomato
  • (SEQ ID NO: 30)
    GGTATGGGGTTGTATCTCTATCTGGTGCCTCAGTTCCCACTTTCCAGGTT
    CACTGAGTCAGTATACCACGAATGGGGTTTCTTCAAACGACTGGGTTACC
    AATATATGGCTGGCTTTACTGCCCGGTGGAAATATTATTTTATTTGGTCA
    ATCTCTGAAGCTTCTATAATCATATCTGGACTGGGTTTCAGTGGTTGGAC
    AAACTCTTCTCCGCCAAAACCACGTTGGGACCGAGCAAAAAATGTTGATG
    TATTGGGTGTTGAGTTAGCAAAGAGCTCGGTTCAGTTACCACTAGTATGG
    AACATTCAAGTCAGCACATGGCTGCGGCATTATGTGTATGAAAGGCTCGT
    ACAGAAGGGAAGGAAGCCTGGTTTCTTCCAGTTGCTGGCTACCCAAACTG
    TCAGTGCCGTTTGGCATGGATTATATCCTGGATACATCATATTCTTTGTT
    CAGTCCGCTTTGATGATTGCTGGATCAAGAGTCATTTACAGATGGCAGCA
    AGCTACAAAAGGTACTATGTTTGAGAAGATACTGATAGCAATGAATTTTG
    CATACACACTGCTGGTTCTAAACTACTCCGCTGTTGGATTCATGGTATTA
    AGTCTGCATGAAACTCTTACTGCTTATGGAAGTGTATACTATATTGGAAC
    AATTGTACCAATTCTTCTCATCCTGCTTAGTAAAGTGATTAAGCCTCCAA
    GACCTGCGACGTCTAAAGCTAGGAAAGCAGAGTAAATCCAAGTCAGTT
  • The partial amino acid sequence of LPCAT from tomato
  • (SEQ ID NO: 31)
                GMGLYLYLVPQFPLSRFTESVYHEWGFFKRLGYQYMAG
    FTARWKYYFIWSISEASIIISGLGFSGWTNSSPPKPRWDRAKNVDVLGVE
    LAKSSVQLPLVWNIQVSTWLRHYVYERLVQKGRKPGFFQLLATQTVSAVW
    HGLYPGYIIFFVQSALMIAGSRVIYRWQQATKGTMFEKILIAMNFAYTLL
    VLNYSAVGFMVLSLHETLTAYGSVYYIGTIVPILLILLSKVIKPPRPATS
    KARKAE
  • (13) The partial nucleotide sequence of LPCAT from Vaccinium corymbosum
  • (SEQ ID NO:32)
    GGGGTTGGGTTACCAGTACATGGCTGGCTTTACAGCACGGTGGAAGTATT
    ATTTCATTTGGTCAATCTCAGAAGCTTCCATCATCATTTCTGGCCTGGGG
    TTCAGTGGTTGGACAGATTCTTCTCCACCAAAACCAAAATGGGACCGTGC
    AAAGAATGTAGATATTTTGCGGGTTGAGTTTGCAAAGACTGCAGCTCAGA
    TTCCACTTGCATGGAACATTCAAGTCAGCACCTGGCTACGCCATTATGTT
    TATGAGAGGCTCGTGCAGAAGGGAAAGAAACCTGGTTTCTTTCAGTTGTT
    GGCTACCCAGACTGTCAGTGCTGTTTGGCATGGTTTATATCCTGGATACA
    TCATATTCTTTGTGCAGTCAGCATTGATGATTGCTGGTTCAAGAGTTATT
    TATAGATGGCAGCAAGCTGTTCCTCCTAAAATGGATCTGGTGAAGAAAGT
    ATTCGTACTTTTAAACTTTGCTTACACAGTTCTGGTGTTGAACTACTCCT
    CTGTCGGTTTCATGGTACTAAGCCTACATGAAACAATTGTTGCATACGGG
    AGCGTGTATTCGTTGGAACCATTGTTCCCATACTTGTAATCCTCCTTGGT
    TACGTAATT
  • The partial amino acid sequence of LPCAT from Vaccinium corymbosum
  • (SEQ ID NO: 33)
    GLGYQYMAGFTARWKYYFIWSISEASIIISGLGFSGWTDSSPPKPKWDRA
    KNVDILRVEFAKTAAQIPLAWNIQVSTWLRHYVYERLVQKGKKPGFFQLL
    ATQTVSAVWHGLYPGYIIFFVQSALMIAGSRVIYRWQQAVPPKMDLVKKV
    FVLLNFAYTVLVLNYSSVGFMYLSLHETIVAYGSVYSLEPLFPYL
  • (14) The partial nucleotide sequence of LPCAT from wheat
  • (SEQ ID NO: 34)
    CACTTTGCTGGACCAGTATATGAGATGAAAGATTATCTTGAATGGACTGA
    AAGGAAAGGAATATGGGCCGGCTCAACTCCTTCACCATTATTACCTACTC
    TGCGTGCTCTAGTTCAGGCTGGAATATGCATGGGGTTATATTTGTATCTG
    TCACCTATGTTTCCCCATTCATAATATAGAGGTTCACTAAATCGTGAAAG
    GGGTTTCTGGCACCGGCTCTTCTTTCAATACATGTCAGGATTTACTGCTC
    GATGGAAATACTACTTTATATGGTCAGTCTCAGAAGCTGCAATTATTATA
    TCTGGCCTGGGTTTCACTGGTTGGTCTGATTCTTCTCCCCCAAAAGCCAA
    ATGGGACCGTGCTATAAATGTTGATATTCTGGGCGTCGAGCTAGCTGGAA
    GTGCAGCTCAATTGCCACTTAAGTGGAATATTCAAGTGAGCACATGGCTA
    AGATACTATGTGTATGAGAGGTTAATTCAGAAAGGGAAGAAGCCTGGTTT
    CCTTCAGTTGTTGGGTACACAGACAGTCAGTGCTATCTGGCATGGACTGT
    ATCCAGGATATATGTTTTTCTTTGTTCAGTCAGCGTTGATGATAAATGGT
    TCAAAAGTTATATACAGATGGCAACAAGCTGTGAGCAATCCAGGCCTCCG
    CACTATCCTGTCTTTACTAAATTGTGCATACACCATGATGGTGCTTAACT
    ACTCATGCATTGGCTTCCAGGTACTGAGCTTCCAGGAGACCTTAGCATCC
    TACAAGAGCGTGTATTATGTCGGCACAATCGTTCCTATTCTATGTGTCTT
    GCTGGGCTATGTCGTCAAGCCCACGAGACCTGTGAAGCCGA
  • The partial amino acid sequence of LPCAT from wheat
  • (SEQ ID NO: 35)
    HFAGPVYEMKDYLEWTERKGIWAGSTPSPLLPTLRALVQAGICMGLYLYL
    SPMFPHS*YRGSLNRERGFWHRLFFQYMSGFTARWKYYFIWSVSEAAIII
    SGLGFTGWSDSSPPKAKWDRAINVDILGVELAGSAAQLPLKWNIQVSTWL
    RYYVYERLIQKGKKPGFLQLLGTQTVSAIWHGLYPGYMFFFVQSALMING
    SKVIYRWQQAVSNPGLRTILSLLNCAYTMMVLNYSCIGFQVLSFQETLAS
    YKSVYYVGTIVPILCVLLGYVVKPTRPVKP
  • (15) The amino acid sequences of LPCAT from A. thaliana
  • Sequence (accession number At1g12640
    (SEQ ID NO: 36))
              MDMSSMAGSIGVSVAVLRFLLCFVATIPVSFACRIVPSRL
    GKHLYAAASGAFLSYLSFGFSSNLHFLVPMTIGYASMAIYRPKCGIITFF
    LGFAYLIGCHVFYMSGDAWKEGGIDSTGALMVLTLKVISCSMNYNDGMLK
    EEGLREAQKKNRLIQMPSLIEYFGYCLCCGSHFAGPVYEMKDYLEWTEGK
    GIWDTTEKRKKPSPYGATIRAILQAAICMALYLYLVPQYPLTRFTEPVYQ
    EWGFLRKFSYQYMAGFTARWKYYFIWSISEASIIISGLGFSGWTDDASPK
    PKWDRAKNVDILGVELAKSAVQIPLVWNIQVSTWLRHYVYERLVQNGKKA
    GFFQLLATQTVSAVWHGLYPGYMMFFVQSALMIAGSRVIYRWQQAISPKM
    AMLRNIMVFINFLYTVLVLNYSAVGFMVLSLHETLTAYGSVYYIGTIIPV
    GLILLSYVVPAKPSRPKPRKEE
    Sequence (accession number At1g63050
    (SEQ ID NO: 37))
              MELLDMNSMAASIGVSVAVLRFLLCFVATIPISFLWRFIP
    SRLGKHIYSAASGAFLSYLSFGFSSNLHFLVPMTIGYASMAIYRPLSGFI
    TFFLGFAYLIGCHVFYMSGDAWKEGGIDSTGALMVLTLKVISCSINYNDG
    MLKEEGLREAQKKNRLIQMPSLIEYFGYCLCCGSHFAGPVFEMKDYLEWT
    EEKGIWAVSEKGKRPSPYGAMIRAVFQAAICMALYLYLVPQFPLTRFTEP
    VYQEWGFLKRFGYQYMAGFTARWKYYFIWSISEASIIISGLGFSGWTDET
    QTKAKWDRAKNVDILGVELAKSAVQIPLFWNIQVSTWLRHYVYERIVKPG
    KKAGFFQLLATQTVSAVWHGLYPGYIIFFVQSALMIDGSKAIYRWQQAIP
    PKMAMLRNVLVLINFLYTVVVLNYSSVGFMVLSLHETLVAFKSVYYIGTV
    IPIAVLLLSYLVPVKPVRPKTRKEE
  • The amino acid sequences of LCPAT from fruit fly, human, mouse, S. pombe and Aspergillus oryzae
  • (1) The amino acid sequences of LCPAT from fruit fly
  • Sequence 1 (accession number AAR99097
    (SEQ ID NO: 38))
    MLEPPKFIENDCYNGSRTFTWLADMVGLSVDLVNFLICQISALFLASLFR
    SMLHPSKVSSKLRHTFALSIGLAFGYFCFGQQAIHIAGLPAICYIVIRTQ
    DPRIVQRAVLLVAMSYLLCVHLMRQLYDYGSYALDITGPLMIITQKVTSL
    AFSIHDGFVRGDEELTKAQQYHAIRKMPSALEYFSYVWHFQSILAGPLVF
    YKDYIEFVEGYNLLSTPPGNGNLDSSKREVVLEPSPTKAVIRKVVGSLVC
    AFIFMKFVKIYPVKDMKEDDFMNNTSMVYKYWYAMMATTCIRFKYYHAWL
    LADAICNNSGLGFTGYDKDGNSKWDLISNINVLSFEFSTNMRDAINNWNC
    GTNRWLRTLVYERVPQQYGTLLTFALSAVWHGFYPGYYLTFATGAVVVTA
    ARTGRRLFRHRFQSTQVTRMFYDILTCLITRVVLGYATFPFVLLEFMGSI
    KLYLRFYLCLHIISLVTIFILPKFIRGERRLRTSNGNGNVRLSGSGNTKD
    AVTTSVESTAALTAGNDLNEDKEEDKHAQCKVHTPTQQQPAAGPHKTTVE
    QPTEQPNNVNLRSRPQQQQPHLEKKAMPPTCARDAVSVPHDQCEMDQLSS
    KLKEKIEAETKNIEEFIDKTVTETVSGIVEFKNDLMRDIEFPKLKLPGSN
    GAISLDSSNGGGLRKRNISSVHDNGTDPGHATADLHPPLEENGAAFLKKE
    IEVINAVVQQAVPAVLSNGHAK
    Sequence 2 (accession number AAO41223
    (SEQ ID NO: 39))
              MAEFEEDLPHNGLMDGIASGVGVPVEALRLLLTILAGYPV
    AALYQKFISVIADKTVHHMFFAGCGAGLCYFNYGLDTYHSLIAILTTYFL
    VLLLRKKTQIFLAINFVFHMSYLLLGYFYTSSNDYDILWTMPHCILVLRM
    IGYGFDITDGLKEESELSKDQKETALKKPPSLLELLAFSYFPSGFLVGPQ
    FPFRRYKAFVDGEFRQHEGNVEAGVRRFGAGAFYLIVCQVGLRYLPDSYF
    LTPEFAQVSFVKRIYLLGFWAKFSLYKYISCWLLTEGALICIGLTYKGED
    KNGQPDWSGCSNVKLKLLETGNTMEHYVQSFNVNTNQWVGQYIYKRLKFL
    NNRTISYGAALGFLAVWHGYHSGYYMTFLMEYMVVSTEKQITRFYTKVVL
    PQWGHILNNSDIYKLLYFITLKSYNVVYMGWCLTAFVFLKYERWIVVYGA
    VSYYGFTFLVLWAAFYHTFNHFFRSSSRKLAGEDQKLQDSNTDKLVEEKK
    PEDKKSE
  • (2) The amino acid sequences of LCPAT from human
  • Sequence 1 (accession number EAX01013
    (SEQ ID NO: 40))
    MKCCFHHIIPRVNFVVCQLFALLAAIWFRTYLHSSKTSSFIRHVVATLLG
    LYLALFCFGWYALHFLVQSGISYCIMIIIGVENMHNYCFVFALGYLTVCQ
    VTRVYIFDYGQYSADFSGPMMIITQKITSLACEIHDGMFRKDEELTSSQR
    DLAVRRMPSLLEYLSYNCNFMGILAGPLCSYKDYITFIEGRSYHITQSGE
    NGKEETQYERTEPSPNTAVVQKLLVCGLSLLFHLTICTTLPVEYNIDEHF
    QATASWPTKIIYLYISLLAARPKYYFAWTLADAINNAAGFGFRGYDENGA
    ARWDLISNLRIQQIEMSTSFKMFLDNWNIQTALWLKRVCYERTSFSPTIQ
    TFILSAIWHGVYPGYYLTFLTGVLMTLAARAMRNNFRHYFIEPSQLKLFY
    DVITWIVTQVAISYTVVPFVLLSIKPSLTFYSSWYYCLHILGILVLLLLP
    VKKTQRRKNTHENIQLSQSKKFDEGENSLGQNSFSTTNNVCNQNQEIASR
    HSSLKQ
    Sequence 2 (accession number Q6ZWT7
    (SEQ ID NO: 41))
    MATTSTTGSTLLQPLSNAVQLPIDQVNFVVCQLFALLAAIWFRTYLHSSK
    TSSFIRHVVATLLGLYLALFCFGWYALHFLVQSGISYCIMIIIGVENMHN
    YCFVFALGYLTVCQVTRVYIFDYGQYSADFSGPMMIITQKITSLACEIHD
    GMFRKDEELTSSQRDLAVRRMPSLLEYLSYNCNFMGILAGPLCSYKDYIT
    FIEGRSYHITQSGENGKEETQYERTEPSPNTAVVQKLLVCGLSLLFHLTI
    CTTLPVEYNIDEHFQATASWPTKIIYLYISLLAARPKYYFAWTLADAINN
    AAGFGFRGYDENGAARWDLISNLRIQQIEMSTSFKMFLDNWNIQTALWLK
    RVCYERTSFSPTIQTFILSAIWHGVYPGYYLTFLTGVLMTLAARAMRNNF
    RHYFIEPSQLKLFYDVITWIVTQVAISYTVVPFVLLSIKPSLTFYSSWYY
    CLHILGILVLLLLPVKKTQRRKNTHENIQLSQSRKFDEGENSLGQNSFST
    TNNVCNQNQEIASRHSSLKQ
    Sequence 3 (accession number Q6P1A2
    (SEQ ID NO: 85))
              MASSAEGDEGTVVALAGVLQSGFQELSLNKLATSLGASEQ
    ALRLIISIFLGYPFALFYRHYLFYKETYLIHLFHTFTGLSIAYFNFGNQL
    YHSLLCIVLQFLILRLMGRTITAVLTTFCFQMAYLLAGYYYTATGNYDIK
    WTMPHCVLTLKLIGLAVDYFDGGKDQNSLSSEQQKYAIRGVPSLLEVAGF
    SYFYGAFLVGPQFSMNHYMKLVQGELIDIPGKIPNSIIPALKRLSLGLFY
    LVGYTLLSPHITEDYLLTEDYDNHPFWFRCMYMLIWGKFVLYKYVTCWLV
    TEGVCILTGLGFNGFEEKGKAKWDACANMKVWLFETNPRFTGTIASFNIN
    TNAWVARYIFKRLKFLGNKELSQGLSLLFLALWHGLHSGYLVCFQMEFLI
    VIVERQAARLIQESPTLSKLAAITVLQPFYYLVQQTIHWLFMGYSMTAFC
    LFTWDKWLKVYKSIYFLGHIFFLSLLFILPYIHKAMVPRKEKLKKME
    Sequence 4 (accession number Q6ZNC8
    (SEQ ID NO: 86))
              MAAEPQPSSLSYRTTGSTYLHPLSELLGIPLDQVNFVVCQ
    LVALFAAFWFRIYLRPGTTSSDVRHAVATIFGIYFVIFCFGWYSVHLFVL
    VLMCYAIMVTASVSNIHRYSFFVAMGYLTICHISRIYIFHYGILTTDFSG
    PLMIVTQKITTLAFQVHDGLGRRAEDLSAEQHRLAIKVKPSFLEYLSYLL
    NFMSVIAGPCNNFKDYIAFIEGKHIHMKLLEVNWKRKGFHSLPEPSPTGA
    VIHKLGITLVSLLLFLTLTKTFPVTCLVDDWFVHKASFPARLCYLYVVMQ
    ASKPKYYFAWTLADAVNNAAGFGFSGVDKNGNFCWDLLSNLNIWKIETAT
    SFKMYLENWNIQTATWLKCVCYQRVPWYPTVLTFILSALWHGVYPGYYFT
    FLTGILVTLAARAVRNNYRHYFLSSRALKAVYDAGTWAVTQLAVSYTVAP
    FVMLAVEPTISLYKSMYFYLHIISLLIILFLPMKPQAHTQRRPQTLNSIN
    KRKTD
    Sequence 5 (accession number XP_001129292
    (SEQ ID NO: 87))
              MVMMMMMKVLLLLMKQRGAGLPAPAGVEPRPSSHHPKARV
    RLQGDESVRPRGCSQLWAFTRHSPRQRGFSARSLFWFVVLPAPTFVPNFP
    WRWLGGVPHIVPPAATPGPFVVCRLSQRGVGGRDIPGRRNRGVRGKDALP
    CSHPRSAPHDAGQPFSGDARHPRAEREVGRALLPATAPGEGGRMGVRVCM
    RSLPFAAAALGSGGRVPEQPPVRMDRVVERVRKAALWGAWRGAACPARAS
    ERPPERLMHGSGDGLLGFSFVRASLTVFGEEAGPSFLLAVLCAVVWGGRG
    EDVVSDVQACPAEQGFLLAEPSVFGVNFVVCQLFALLAAIWFRTYLHSSK
    TSSFIRHVVATLLGLYLALFCFGWYALHFLVQSGISYCIMIIIGVENMHN
    YCFVFALGYLTVCQVTRVYIFDYGQYSADFSGPMMIITQKITSLACEIHD
    GMFRKDEELTSSQRDLAVRRMPSLLEYLSYNCNFMGILAGPLCSYKDYIT
    FIEGRSYHITQSGENGKEETQYERTEPSPNTAVVQKLLVCGLSLLFHLTI
    CTTLPVEYNIDEHFQATASWPTKIIYLYISLLAARPKYYFAWTLADAINN
    AAGFGFRGYDENGAARWDLISNLRIQQIEMSTSFKMFLDNWNIQTALWLK
    RVCYERTSFSPTIQTFILSAIWHGVYPGYYLTFLTGVLMTLAARAMRNNF
    RHYFIEPSQLKLFYDVITWIVTQVAISYTVVPFVLLSIKPSLTFYSSWYY
    CLHILGILVLLLLPVKKTQRRKNTHENIQLSQSKKFDEGENSLGQNSFST
    TNNVCNQNQEIASRHSSLKQ
    Sequence 6 (accession number XP_001131044
    (SEQ ID NO: 88))
              MVNFVVCQLVALFAAFWFRIYLRPGTTSSDVRHAVATIFG
    IYFVIFCFGWYSVHLFVLVLMCYAIMVTASVSNIHRYSFFVAMGYLTICH
    ISRIYIFHYGILTTDFSGPLMIVTQKITTLAFQVHDGLGRRAEDLSAEQH
    RLAIKVKPSFLEYLSYLLNFMSVIAGPCNNFKDYIAFIEGKHIHMKLLEV
    NWKRKGFHSLPEPSPTGAVIHKLGITLVSLLLPLTLTKTFPVTCLVDDWF
    VHKASFPARLCYLYVVMQASKPKYYFAWTLADAVNNAAGFGFSGVDKNGN
    FCWDLLSNLNIWKIETATSFKMYLENWNIQTATWLKCVCYQRVPWYPTVL
    TFILSALWHGVYPGYYFTFLTGILVTLAARAVRNNYRHYFLSSRALKAVY
    DAGTWAVTQLAVSYTVAPFVMLAVEPTISLYKSMYFYLHIISLLIILFLP
    MKPQAHTQRRPQTLNSINKRKTD
  • (3) The amino acid sequences of LCPAT from mouse
  • Sequence 1 (accession number AAH24653
    (SEQ ID NO: 42))
              MAARPPASLSYRTTGSTCLHPLSQLLGIPLDQVNFVACQL
    FALSAAFWFRIYLHPGKASPEVRHTLATILGIYFVVFCFGWYAVHLFVLV
    LMCYGVMVSASVSNIHRYSFFVAMGYLTICHISRIYIFHYGILTTDFSGP
    LMIVTQKITTLAFQVHDGLGRKAEDLSAEQHRLAVKAKPSLLEYLSYHLN
    FMSVIAGPCNNFKDYVAFIEGRHIHMKLLEVNWTQRGFQSLPEPSPTGAV
    IQKLCVTLMSLLLFLTLSKSFPVTFLIDDWFVHKANFLSRLWYLYVVMQA
    AKPKYYFAWTLADAVHNAAGFGFNGMDTDGKSRWDLLSNLNIWKIETATS
    FKMYLENWNIQTSTWLKCVCYERVSWYPTVLTFLLSALWHGVYPGYYFTF
    LTGVPVTLAARAVRNNYRHHFLSSKARKIAYDVVTWAVTQLAVSYTAAPF
    VMLAVEPTISLYKSVFFFLHIICLLIILFLPIKPHQPQRQSRSPNSVKKK
    AD
    Sequence 2 (accession number AAH25429
    (SEQ ID NO: 43))
    MATTSTTGSTLLQPLSNAVQLPIDQVNFVVCQLFALLAAVWFRTYLHSSK
    TSSFIRHVVATLLGLYLAFFCFGWYALHFLVQSGISYCIMIIAGVESMQQ
    CCFVFALGYLSVCQITRVYIFDYGQYSADFSGPMMIITQKITSLAYEIHD
    GMFRKDEELTPSQRGLAVRRMPSLLEYVSYTCNFMGILAGPLCSYKDYIA
    FIEGRASHVAQPSENGKDEQHGKADPSPNAAVTEKLLVCGLSLLFHLTIS
    NMLPVEYNIDEHFQATASWPTKATYLYVSLLAARPKYYFAWTLADAINNA
    AGFGFRGYDKNGVARWDLISNLRIQQIEMSTSFKMFLDNWNIQTALWLKR
    VCYERATFSPTIQTFFLSAIWHGVYPGYYLTFLTGVLMTLAARAVRWRFR
    HYFLEPPQLKLFYDLITWVATQITISYTVVPFVLLSIKPSFTFYSSWYYC
    LHVCSILVLLLLPVKKSQRRTSTQENVHLSQAKKFDERDNPLGQNSFSTM
    NNVCNQNRDTGSRHSSLTQ
  • (4) The amino acid sequences of LCPAT from S. pombe
  • Sequence (accession number CAA16861
    (SEQ ID NO: 44))
              MAYLIDIPFEYFSSFLGVHPDQLKLLFCFLSAYPFAGILK
    RLPSAPWIRNLFSISIGLFYLIGVHHLYDGVLVLLFDALFTYFVAAFYRS
    SRMPWIIFWILGHTFSSHVIRYIYPSENTDITASQMVLCMKLTAFAWSVY
    DGRLPSSELSSYQKDRALRKIPNILYFLGYVFFFPSLLVGPAFDYVDYER
    FITLSMFKPLADPYEKQITPHSLEPALGRCWRGLLWLILFITGSSIYPLK
    FLLTPKFASSPILLKYGYVCITAFVARMKYYGAWELSDGACILSGIGYNG
    LDSSKHPRWDRVKNIDPIKFEFADNIKCALEAWNMNTNKWLRNYVYLRVA
    KKGKRPGFKSTLSTFTVSAMWHGVSAGYYLTFVSAAFIQTVAKYTRRHVR
    PFFLKPDMETPGPFKRVYDVIGMVATNLSLSYLIISFLLLNLKESIHVWK
    ELYFIVHIYILIALAVFNSPIRSKLDNKIRSRVNSYKLKSYEQSMKSTSD
    TDMLNMSVPKREDFENDE
  • (5) The amino acid sequences of LCPAT from Aspergillus oryzae
  • Sequence (accession number BAE61812
    (SEQ ID NO: 45))
    MLPYVDLLKLIASFLLSYPLAALLKRIPDAQPWKKNAFIIAVSLFYLVGL
    FDLWDGLRTLAYSAAGIYAIAYYIDGSLMPWIGFIFLMGHMSISHIYRQI
    IDDAHVTDITGAQMVLVMKLSSFCWNVHDGRLSQEQLSDPQKYAAIKDFP
    GILDYLGYVLFFPSLFAGPSFEYVDYRRWIDTTLFDVPPGTDPSKVPPTR
    KKRKIPRSGTPAAKKALAGLGWILAFLQLGSLYNQELVLDETFMQYSFVQ
    RVWILHMLGFTARLKYYGVWYLTEGACVLSGMGYNGFDPKSGKVFWNRLE
    NVDPWSLETAQNSHGYLGSWNKNTNHWLRNYVYLRVTPKGKKPGFRASLA
    TFVTSAFWHGFYPGYYLTFVLGSFIQTVAKNFRRHVRPFFLTPDGSRPTA
    YKKYYDIASYVVTQLTLSFAVMPFIFLSFGDSIKVWHSVYFYGIVGNIVS
    LAFFVSPARGLLLKKLKARNKPHVPRAVSSENIRQPTLGLPNDAIQEFDD
    AVQEIRAEIESRQRRGSLAHMPIGDELKAAVEDKIGRGH
  • Alignment of the LPCAT sequences from different species that reveals four conserved motifs unique for this novel type of LPCAT enzymes (FIG. 2). They are not present in the previously identified glycerol-3-phosphate acyltransferases, lyso-phosphatidic acid acyltransferases, and known LPCAT enzymes. The sequences of these motifs are as follows. The letter “φ” represents a certain amino acid.
  • Motif 1: M V(I) L(I) φ φ K L(V,I) φ φ φ φ φ φ D G (or Met Xaa Xaa Xaa Xaa Lys Xaa Xaa Xaa Xaa Xaa Xaa Xaa Asp Gly (SEQ ID NO:46), wherein the Xaa at position 2 can be Val or Ile, the Xaa at position 3 can be Leu or Ile, the Xaa at position 7 can be Leu, Val, or Ile, while the other Xaa's in the motif may be any amino acid.
  • Motif 2: R φ K Y Y φ φ W φ φ φ E(D) A(G) φ φ φ φ G φ G F(Y) φ G (or Arg Xaa Lys Tyr Tyr Xaa Xaa Trp Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Gly Xaa Gly Xaa Xaa Gly (SEQ ID NO:47), wherein the Xaa at position 12 is Glu or Asp, wherein the Xaa at position 13 is Ala or Gly, wherein the Xaa at position 22 is Phe or Tyr, while the other Xaa's in the motif may be any amino acid.
  • Motif 3: E φ φ φ φ φ φ φ φ φ φ φ W N φ φ T(V) φ φ W (or Glu Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Trp Asn Xaa Xaa Xaa Xaa Xaa Trp (SEQ ID NO:48) wherein the Xaa at position 17 is Thr or Val, while the other Xaa's in the motif may be any amino acid.
  • Motif 4: S A φ W H G φ φ P G Y φ φ T(F) F (or Ser Ala Xaa Trp His Gly Xaa Xaa Pro Gly Tyr Xaa Xaa Xaa Phe (SEQ ID NO:49) wherein Xaa at position 14 is Thr or Phe, while the other Xaa's in the motif may be any amino acid.
  • FIG. 3 depicts another alignment of LPCAT sequences from different plant species that revealed the following motifs:
  • Motif 5 (SEQ ID NO: 81):
    E A φ φ I I(L) S G φ G F S(T) G W;
    Motif 6 (SEQ ID NO: 82):
    W D R A φ N V D;
    Motif 7 (SEQ ID NO: 83):
    W N I Q V S T W L φ φ Y V Y;
    and
    Motif 8 (SEQ ID NO: 84):
    G F φ Q L L φ T Q T φ S A φ W H G L Y P G Y.
  • EXAMPLE 7 Analysis of LPCAT from the Alga Thalassiosira pseudonana
  • Materials and Methods
  • Isolation of the LPCAT cDNA from T. pseudonana: PCR primers were designed for nucleotide sequence of the putative TpLPCAT obtained by a BLAST search of the sequenced T. pseudonana genome using the yeast LPCAT sequence. Plasmid from a cDNA library of T. pseudonana was used as template. A 50 μl PCR reaction contained 50 ng of plasmid DNA, 20 pM of each primer: 5′-GGTATGCTCATCTGCTACCCCCTC-3′ (SEQ ID NO:89) and 5′-TTAAGTCTCCTTCGTCTTTGGTGTAG-3′ (SEQ ID NO:90) and 1 μl of BD Advantage™ 2 Polymerase Mix (Clontech Laboratories, Inc.), and was amplified in a thermocycler during 30 cycles of the following program: 94° C for 30 sec, 58° C. for 30 sec, and 72° C. for 1 min 30 sec. The PCR product was purified, and subsequently cloned into the pYES2.1/V5-His-TOPO expression vector (Invitrogen).
  • Expression of TpLPCAT in yeast: The TpLPCAT in pYES2.1/V5-His-TOPO plasmid was transformed into yeast lpcat mutant By02431 using the method provided by the producer's manual (Invitrogen). Yeast cells transformed with pYES2.1/V5-His-TOPO plasmid only were used as a control. Transformants were selected by growth on synthetic complete medium lacking uracil (SC-ura), supplemented with 2% (w/v) glucose. The colonies were transferred into liquid SC-ura with 2% (w/v) glucose and grown at 28° C. overnight. The overnight cultures were diluted to an OD 0.4 in induction medium (SC-ura+2% Galactose+1% Raffinose), and were induced by incubating at 28° C. for 24 hours. The yeast cells were collected and broken using glass beads. The protein concentrations in the lysates were normalized using the Biorad assay (Bradford 1976) and then assayed for LPCAT activity.
  • Identification of LPCAT from the algae Thalassiosira pseudonana
  • Isolation of the LPCAT cDNA from T. pseudonana A full-length T. pseudonana LPCAT cDNA clone was amplified by PCR from an algae cDNA library. The nucleotide sequence had an open reading frame of 1,323 bp encoding a polypeptide of 440 amino acids with a calculated molecular mass of 49.75 kD
  • Expression of TpLPCAT in Yeast: To confirm the function of the protein encoded by the TpLPCAT, the full-length coding region of TpLPCAT was cloned into a yeast expression vector pYES2.1/V5-His-TOPO under the control of the galactose-inducible GAL1 promoter, and the construct was used to transform a LPCAT-deficient yeast strain By02431(a yeast lpcat strain). Yeast cells harboring an empty pYES2.1 vector plasmid were used as a control. We also discovered that the yeast lpcat strain is hypersensitive to lyso-PAF (lyso-Platelet-activating factor, 1-O-alkyl-sn-glycero-3-phosphocholine). Expression of the TpLPCAT in yeast lpcat mutant was able to overcome lyso-PAF the sensitivity of the lpcat mutant (FIG. 4).
  • The microsomal membrane fractions prepared from lysates of the induced yeast cells were assayed for LPCAT activity using 14C-labelled Lyso-PC as acceptor, and different unlabeled acyl-CoAs as acyl donors. Under our assay conditions, expression of the TpLPCAT in yeast lpcat mutant resulted in a restoration of LPCAT function and produced a recombinant LPCAT protein capable of incorporating a range of different acyl-CoAs into PC including 14:0-, 16:0-, 16:1-, 18:0-, 18:1-, 18:2-, and 22:6(DHA)-, with the most preference of 18:1-CoA, and efficiently utilization of the very long chain polyunsaturated fatty acid--22:6-CoA(DHA) (FIGS. 5 & 6).
  • EXAMPLE 8 Arabidopsis Gene Assays
  • Experimental procedure:
  • TA-cloning and yeast complementation: Total RNA was prepared from Arabidopsis seedlings using RNeasy Plant Mini Kit (Qiagen). RT-PCR of the ORFs of Arabidopsis Atlg12460, Atlg63050 was performed with primer pairs designed based on sequences of gene annotation available at TAIR (The Arabidopsis Information Resources). The cDNA was cloned into vector pYES2.1 using pYES2.1 TOPO TA Cloning Kit according to the manufacturer's protocol (Invitrogen). Correctly-oriented positive colonies were identified through double digestion with restriction enzyme, followed by verification through DNA sequencing. The construct was introduced into yeast strain YOR175c, BY02431. Yeast extract, Yeast Nitrogen Base, Bacto-peptone, and Bacto-agar were purchased from Difco™, D-glucose, D-galactose and D-raffinose were from Sigma. SC minimal medium and plates was prepared according to Invitrogen's recipe described for the pYES2.1 TOPO TA Cloning Kit.
  • Lyso-PAF sensitivity: Yeast strains BY02431 carrying pYES 2.1-AtLPCATs or the empty vector were first grown in 15 ml of SC-Leu-His-ura medium containing 2% glucose. Yeast transformant strains of AtLPCATs were first grown in YPD overnight. Protein expression induction were carried out by protocol described in Invitrogen manufacturer manual for yeast expression vector pYES2.1. After 12 hr induction, 5 μl cultures were inoculated onto YPD plate with 10 μg/ml LysoPAF. The plates were incubated at 28° C. for 2 days. The final lysoPAF is 10 μg/ml.
  • In vitro assay: Yeast strains BY02431 carrying pYES 2.1-AtLPCATs or the empty vector were first grown in 15 ml of SC-Leu-His-ura medium containing 2% glucose. Yeast transformant strains of AtLPCATs were first grown in YPD overnight. Protein expression induction were carried out by protocol described in Invitrogen manufacturer manual for yeast expression vector pYES2.1. After 24 hr of growth in the galactose induction conditions, the cells were washed first with distilled water and then with wall-breaking buffer (50 mM sodium phosphate, pH7.4; 1 mM EDTA; 1 mM PMSF; 5% glycerol) and spun down at 4,000 rpm (Eppendorf Centrifuge 5145C) to re-pellet cells. The cells, resuspended in 1 ml cell wall-breaking buffer, were shaken vigorously in the presence of acid-washed glass beads (diameter 0.5 mm) in a mini-bead beater at 5,000 rpm for 3′ 1-min intervals. The resultant homogenate was centrifuged at 1,500′ g for 5 min at 4° C. The supernatant was decanted for in vitro assay. Protein concentration was measured using Bio-Rad Protein Assay Kit for final AtSAT1 activity calculation.
  • AtLPCAT substrate specificity was determined by counting incorporation of 14C-labeled lysophosphatidylcholine or 14C-labled palmityl-CoA into phosphatidylcholine. All assays were performed at least twice. 200 ml reaction mixture contained 50 mg microsomal protein, 50 mM acyl-CoA and 45 mM palmitoyl-PC, pH7.4. 14C-lysophosphatidylcholine (1.4 nCi/nmol) or 14C-palmityl-CoA (5.5 nCi/nmol) was used to assess fatty-CoA or lyso-lipid substrate specificity. Reaction was allowed for 10 min at 30° C. All radiolabel chemicals for these assays were purchased from ARC, Inc.
  • Lyso-PAF sensitivity test (FIG. 7): The yeast lpcat strain is deficient in its endogenous LPCAT and hypersensitive to lyso-PAF (lyso-Platelet-activating factor, 1-O-alkyl-sn-glycero-3-phosphocholine). The lpcat yeast mutant is incapable of growth in the presence of 10 ug/ml lyso-PAF (lyso-Platelet-activating factor, 1-O-alkyl-sn-glycero-3-phosphocholine). However, when the Arabidopsis LPCAT genes, Atlg12640 and Atlg63050, were introduced into the yeast mutant, the transformants could survive on lyso-PAF-containing YPD plate. These results indicated that the Arabidopsis genes encode for LPCAT.
  • In vitro enzyme characterization with the yeast cell free lysate expressing the Arabidopsis LPCATs was further conducted.
  • Lyso-lipid substrate specificity (FIG. 8): LPA (lysophosphatidic acid), LPC (lysophosphatidic choline), LPE (lysophosphatidylethanolamine), LPG (lysophosphatidylglycerol), LPI (lysophosphatidyl inositol) and LPS (lysophosphatidyl serine) were first tested as substrates to compare their acyltransferase activity. The results clearly showed that Atlg12640 and Atlg63050 both exhibited high activity towards LPC (FIG. 8).
  • References: The contents of the following references are incorporated herein in their entirety.
  • Abbadi A, Domergue F, Bauer J, Napier J A, Welti R, Zähinger U, Cirpus P, Heinz E (2004). Biosynthesis of very-long-chain polyunsaturated fatty acids in transgenic oilseeds: constraints on their accumulation. Plat Cell 16: 2734-2748.
    Bechtold, N., Ellis, J. and Pellefer, G. (1993) In planta Agrobacterium-mediated gene transfer by infiltration of adult Arabidopsis thaliana plants. C.R. Acad. Sci. Ser. Ill Sci. Vie, 316: 1194-1199.
    Becker, D., Brettschneider, R. and. Lorz, H. (1994) Fertile transgenic wheat from microprojectile bombardment of scutellar tissue. PIant J. 5: 299-307.
    Chen X, Hyatt B A, Mucenski M L, Mason R J, Shannon J M (2006). Identification and characterization of a lysophosphatidylcholine acyltransferase in alveolar type II cells. Proc. Natl. Acad. Sci. USA103: 11724-11729.
    Datla, R, Anderson, J. W. and Selvaraj, G. (1997) Plant promoters for transgene expression. Biotechnology Annual Review 3: 269-296.
    DeBlock, M., DeBrouwer, D. and Tenning, P. (1989) Transformation of Brassica napus and Brassica oleracea using Agrobacterium tumefaciens and the expression of the bar and neo genes in the transgenic plants. Plant Physiol. 91: 694-701.
    Domergue F, Abbadi A, Heinz E (2005). Relief for fish stocks: oceanic fatty acids in transgenic oilseeds. Trend Plant Sci 10: 112-116.
    Huang Y S, Pereira S L, Leonard A E (2004). Enzymes for transgenic biosynthesis of long-chain polyunsaturated fatty acids. Biochimie 86: 793-798.
    Katavic, Y., Haughn, G. W., Reed, D., Martin, M. and Kunst, L. (1994) In planta transformation of Arabidopsis thaliana. Mol. Gen. Genet. 245: 363-370.
    Meyer, P. (1995) Understanding and controlling transgene expression. Trends in Biotechnology:13: 332-337.
    Moloney, M. M., Walker, J. M. and. Sharma, K. K. (1989) High efficiency transformation of Brassica napus using Agrobacterium vectors. Plant Cell Rep. 8: 238-242.
    Napier J A, Beaudoin F, Michaelson L V, Sayanova O (2004). The production of long chain polyunsaturated fatty acids in transgenic plants by reverse-engineering. Biochimic 86: 785-793.
    Nehra, N. S., Chibbar, R. N., Leung, N., Caswell, K., Mallard, C., Steinhauer, L. Baga, M. and Kartha, K. K. (1994) Self-fertile transgenic wheat plants regenerated from isolated. scutellar tissues following microprojectile bombardment with two distinct gene constructs. Plant J 5: 285-297.
    Potrykus, L. (1991) Gene transfer to plants: Assessment of publish approaches and results. Annu. Rev. Plant Physiol. Plant Mol. Biol. 42: 205-225.
    Pouwels et al., Cloning Vectors. A laboratory manual, Elsevier, Amsterdam (1986).
    Qi B, Fraser T, Mugford S, Dobson G, Sayanova O, Butler J, Napier J A, Stobart A K, Lazarus C M (2004). Production of very long chain polyunsaturated omega-3 and omega-6 fatty acids in plants. Nat Biotechnol 22: 739-745.
    Rhodes, C. A., Pierce, D. A., Mettler, I. J., Mascarenhas, D. and Detmer, J. J. (1988) Genetically transformed maize plants from protoplasts. Science 240: 204-207.
    Sanford, J. C., Klein, T. M., Wolf, E. D. and Allen, N. (1987) Delivery of substances into cells and tissues using a particle bombardment process. J. Part. Sci. Technol. 5: 27-37.
    Shimamoto, K., Terada, R., Izawa, T. and Fujimoto, H. (1989) Fertile transgenic rice plants regenerated from transformed protoplasts. Nature 335: 274-276.
    Shindou H, Hishikawa D, Nakanishi H, Harayama T, Ishii S, Taguchi R, Shimizu T (2007). A single enzyme catalyzes both platelet-activating factor production and membrane biogenesis of inflammatory cells: Cloning and characterization of acetyl-CoA: lyso-PAF acetyltransferase. J Biol Chem. 282: 6532-6539.
    Songstad D. D., Somers, D. A. and. Griesbach, R. J. (1995) Advances in alternative DNA delivery techniques. Plant Cell, Tissue and Organ Culture 40: 1-15.
    Testet E, Laroche-Traineau J, Noubhani A, Coulon D, Bunoust O, Camougrand N, Manon S, Lessire R, Bessoule J J (2005). Ypr140wp, ‘the yeast tafazzin’, displays a mitochondrial lysophosphatidylcholine (lyso-PC) acyltransferase activity related to triacylglycerol and mitochondrial lipid synthesis. Biochem J 387: 617-626.
    Vasil, I. K. (1994) Molecular improvement of cereals. Plant Mol. Biol. 5: 925-937.
    Walden, R. and Wingender, R. (1995) Gene-transfer and plant regeneration techniques. Trends in Biotechnology 13: 324-331.
    Wu G, Truksa M, Datla N, Vrinten P, Bauer J, Zank T, Cirpus P, Heinz E, Qiu X (2005). Stepwise engineering to produce high yields of very long-chain polyunsaturated fatty acids in plants. Nat Biotechnol 23: 1013-1017.

Claims (10)

1-5. (canceled)
6. A method for identifying a lyso-phosphatidylcholine acyltransferase, the method comprising:
screening a peptide or a nucleic acid sequence encoding the peptide for SEQ ID NO: 49 or the corresponding nucleic acid sequences thereto.
7. (canceled)
8. The method according to claim 6, further comprising screening the peptide or the nucleic acid sequence encoding the peptide for SEQ ID NO: 46 or the corresponding nucleic acid sequence to SEQ ID NO: 46.
9. The method according to claim 6, further comprising screening the peptide or the nucleic acid sequence encoding the peptide for SEQ ID NO: 47 or the corresponding nucleic acid sequence to SEQ ID NO: 47.
10. The method according to claim 6, further comprising screening the peptide or the nucleic acid sequence encoding the peptide for SEQ ID NO: 48 or the corresponding nucleic acid sequence to SEQ ID NO: 48.
11. The method according to claim 6, further comprising screening the peptide or the nucleic acid sequence encoding the peptide for SEQ ID NO: 46 and SEQ ID NO: 47 or the corresponding nucleic acid sequences to SEQ ID NO: 46 and SEQ ID NO: 47.
12. The method according to claim 6, further comprising screening the peptide or the nucleic acid sequence encoding the peptide for SEQ ID NO: 47 and SEQ ID NO: 48 or the corresponding nucleic acid sequences to SEQ ID NO: 47 and SEQ ID NO: 48.
13. The method according to claim 6, further comprising screening the peptide or the nucleic acid sequence encoding the peptide for SEQ ID NO: 46 and SEQ ID NO: 48 or the corresponding nucleic acid sequences to SEQ ID NO: 46 and SEQ ID NO: 48.
14. The method according to claim 6, further comprising screening the peptide or the nucleic acid sequence encoding the peptide for SEQ ID NO: 46, SEQ ID NO: 47, and SEQ ID NO: 48 or the corresponding nucleic acid sequences to SEQ ID NO: 46, SEQ ID NO: 47, and SEQ ID NO: 48.
US11/820,014 2006-12-13 2007-06-15 Methods for identifying lysophosphatidylcholine acyltransferases Expired - Fee Related US7732155B2 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
US11/820,014 US7732155B2 (en) 2006-12-13 2007-06-15 Methods for identifying lysophosphatidylcholine acyltransferases
AU2007334364A AU2007334364B2 (en) 2006-12-13 2007-12-13 Genes encoding a novel type of lysophophatidylcholine acyltransferases and their use to increase triacylglycerol production and/or modify fatty acid composition
CA2671674A CA2671674C (en) 2006-12-13 2007-12-13 Genes encoding a novel type of lysophophatidylcholine acyltransferases and their use to increase triacylglycerol production and/or modify fatty acid composition
PCT/US2007/025650 WO2008076377A2 (en) 2006-12-13 2007-12-13 Genes encoding a novel type of lysophophatidylcholine acyltransferases and their use to increase triacylglycerol production and/or modify fatty acid composition
CA2862907A CA2862907C (en) 2006-12-13 2007-12-13 Genes encoding a novel type of lysophophatidylcholine acyltransferases and their use to increase triacylglycerol production and/or modify fatty acid composition
US12/448,061 US8383886B2 (en) 2006-12-13 2007-12-13 Genes encoding a novel type of lysophophatidylcholine acyltransferases and their use to increase triacylglycerol production and/or modify fatty acid composition
US13/745,257 US9228175B2 (en) 2006-12-13 2013-01-18 Genes encoding a novel type of lysophophatidylcholine acyltransferases and their use to increase triacylglycerol production and/or modify fatty acid composition

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US87449706P 2006-12-13 2006-12-13
US11/820,014 US7732155B2 (en) 2006-12-13 2007-06-15 Methods for identifying lysophosphatidylcholine acyltransferases

Related Child Applications (2)

Application Number Title Priority Date Filing Date
PCT/US2007/025650 Continuation WO2008076377A2 (en) 2006-12-13 2007-12-13 Genes encoding a novel type of lysophophatidylcholine acyltransferases and their use to increase triacylglycerol production and/or modify fatty acid composition
US12/448,061 Continuation US8383886B2 (en) 2006-12-13 2007-12-13 Genes encoding a novel type of lysophophatidylcholine acyltransferases and their use to increase triacylglycerol production and/or modify fatty acid composition

Publications (2)

Publication Number Publication Date
US20080145867A1 true US20080145867A1 (en) 2008-06-19
US7732155B2 US7732155B2 (en) 2010-06-08

Family

ID=39527771

Family Applications (3)

Application Number Title Priority Date Filing Date
US11/820,014 Expired - Fee Related US7732155B2 (en) 2006-12-13 2007-06-15 Methods for identifying lysophosphatidylcholine acyltransferases
US12/448,061 Expired - Fee Related US8383886B2 (en) 2006-12-13 2007-12-13 Genes encoding a novel type of lysophophatidylcholine acyltransferases and their use to increase triacylglycerol production and/or modify fatty acid composition
US13/745,257 Expired - Fee Related US9228175B2 (en) 2006-12-13 2013-01-18 Genes encoding a novel type of lysophophatidylcholine acyltransferases and their use to increase triacylglycerol production and/or modify fatty acid composition

Family Applications After (2)

Application Number Title Priority Date Filing Date
US12/448,061 Expired - Fee Related US8383886B2 (en) 2006-12-13 2007-12-13 Genes encoding a novel type of lysophophatidylcholine acyltransferases and their use to increase triacylglycerol production and/or modify fatty acid composition
US13/745,257 Expired - Fee Related US9228175B2 (en) 2006-12-13 2013-01-18 Genes encoding a novel type of lysophophatidylcholine acyltransferases and their use to increase triacylglycerol production and/or modify fatty acid composition

Country Status (3)

Country Link
US (3) US7732155B2 (en)
CA (2) CA2862907C (en)
WO (1) WO2008076377A2 (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010110375A1 (en) * 2009-03-26 2010-09-30 サントリーホールディングス株式会社 Novel lysophospholipid acyltransferase
WO2010130725A1 (en) * 2009-05-13 2010-11-18 Basf Plant Science Company Gmbh Acyltransferases and uses thereof in fatty acid production
US20100317882A1 (en) * 2009-06-16 2010-12-16 E. I. Du Pont De Nemours And Company LONG CHAIN OMEGA-3 AND OMEGA-6 POLYUNSATURATED FATTY ACID BIOSYNTHESIS BY EXPRESSION OF ACYL-CoA LYSOPHOSPHOLIPID ACYLTRANSFERASES
WO2010147907A1 (en) 2009-06-16 2010-12-23 E. I. Du Pont De Nemours And Company High eicosapentaenoic acid oils from improved optimized strains of yarrowia lipolytica
WO2013192007A1 (en) 2012-06-19 2013-12-27 E. I. Du Pont De Nemours And Company MUTANT ACYL-CoA:LYSOPHOSPHATIDYLCHOLINE ACYLTRANSFERASES
US20140161959A1 (en) * 2009-12-24 2014-06-12 E.I. Du Pont De Nemours And Company Plant Membrane O-Acyl Transferase (MBOAT) Family Protein Sequences and their Uses for Altering Fatty Acid Compositions
WO2014100061A1 (en) 2012-12-21 2014-06-26 E. I. Du Pont De Nemours And Company Down-regulation of a polynucleotide encoding a sou2 sorbitol utilization protein to modify lipid production in microbial cells
US9701989B2 (en) 2012-12-21 2017-07-11 E I Du Pont De Nemours And Company Recombinant microbial cells that produce at least 28% eicosapentaenoic acid as dry cell weight
AU2015202044B2 (en) * 2009-05-13 2017-11-23 Basf Plant Science Company Gmbh Acyltransferases and uses thereof in fatty acid production
CN113527464A (en) * 2021-07-19 2021-10-22 新景智源生物科技(苏州)有限公司 TCR recognizing MBOAT2

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7732155B2 (en) 2006-12-13 2010-06-08 National Research Council Of Canada Methods for identifying lysophosphatidylcholine acyltransferases
WO2009001315A2 (en) * 2007-06-26 2008-12-31 Staahl Ulf Use of a class of genes encoding lysophospholipid acyl transferases for application in agriculture, biotechnology, and medicine
CA2724995A1 (en) 2008-05-21 2009-11-26 National Research Council Of Canada Reduction of lyso-phosphatidylcholine acyltransferase activity
NO2443248T3 (en) * 2009-06-16 2018-05-26
JP5798729B2 (en) 2009-12-25 2015-10-21 花王株式会社 Method for producing fatty acid-containing lipid using modified thioesterase
JP5764339B2 (en) 2010-05-06 2015-08-19 花王株式会社 Thiesterase and method for producing fatty acid or lipid using the same
JP5925651B2 (en) 2012-09-20 2016-05-25 花王株式会社 Method for producing lipid using modified thioesterase
WO2015031335A1 (en) 2013-08-28 2015-03-05 Brookhaven Science Associates Llc Engineering cyclopropane fatty acid accumulation in plants

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050028558A1 (en) * 2003-08-06 2005-02-10 Hoya Corporation Process for producing glass molded lens
US20060046253A1 (en) * 2004-09-02 2006-03-02 Suntory Limited Method for analyzing genes of industrial yeasts

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69231875T2 (en) 1991-04-09 2001-10-04 Unilever N.V., Rotterdam PLANT PROMOTER INVOLVES IN CONTROL OF LIPID BIOSYNTHESIS IN SEEDS
US6500670B1 (en) * 1997-02-10 2002-12-31 National Research Council Of Canada Plant pyruvate dehydrogenase kinase gene
US6265636B1 (en) * 1998-06-19 2001-07-24 Pioneer Hi-Bred International, Inc. Pyruvate dehydrogenase kinase polynucleotides, polypeptides and uses thereof
US7135617B2 (en) * 1998-07-02 2006-11-14 Calgene Llc Diacylglycerol acyl transferase proteins
US7015373B1 (en) * 1998-12-17 2006-03-21 National Research Council Of Canada Diacylglycerol acyltransferase gene from plants
WO2001021820A1 (en) * 1999-09-22 2001-03-29 National Research Council Of Canada Transgenic manipulation of sn-glycerol-3-phosphate and glycerol production with a feedback defective glycerol-3-phosphate dehydrogenase gene
US7759547B2 (en) 1999-09-22 2010-07-20 National Research Council Of Canada Methods of producing and growing plants having improved phosphorus utilization
US20050208558A1 (en) 1999-10-19 2005-09-22 Applera Corporation Detection kits, such as nucleic acid arrays, for detecting the expression or 10,000 or more Drosophila genes and uses thereof
ATE498013T1 (en) * 2000-05-12 2011-02-15 Cropdesign Nv NUCLEIC ACID CODING FOR CELL CYCLE PROTEINS AND THEIR USE
US7214859B2 (en) * 2002-08-16 2007-05-08 National Research Council Of Canada Brassica pyruvate dehydrogenase kinase gene
US7732155B2 (en) * 2006-12-13 2010-06-08 National Research Council Of Canada Methods for identifying lysophosphatidylcholine acyltransferases
EP2234474B1 (en) 2007-12-21 2016-10-26 National Research Council of Canada Diacylglycerol acyltransferase 2 genes and proteins encoded thereby from algae
CA2717940C (en) 2008-03-26 2019-08-13 Zhifu Zheng Algal glycerol-3-phosphate acyltransferase
US7983064B2 (en) * 2008-09-08 2011-07-19 Cheng Uei Precision Industry Co., Ltd. Power adapter
US9410160B2 (en) * 2009-04-10 2016-08-09 Dow Agrosciences Llc Plant SNF1-related protein kinase gene

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050028558A1 (en) * 2003-08-06 2005-02-10 Hoya Corporation Process for producing glass molded lens
US20060046253A1 (en) * 2004-09-02 2006-03-02 Suntory Limited Method for analyzing genes of industrial yeasts

Cited By (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8790906B2 (en) 2009-03-26 2014-07-29 Suntory Holdings Limited Lysophospholipid acyltransferase
US9315835B2 (en) 2009-03-26 2016-04-19 Suntory Holdings Limited Lysophospholipid acyltransferase
WO2010110375A1 (en) * 2009-03-26 2010-09-30 サントリーホールディングス株式会社 Novel lysophospholipid acyltransferase
US9212371B2 (en) 2009-05-13 2015-12-15 Basf Plant Science Company Gmbh Acyltransferases and uses thereof in fatty acid production
EP2821492A3 (en) * 2009-05-13 2015-04-08 BASF Plant Science Company GmbH Acyltransferases and uses thereof in fatty acid production
AU2015202044B2 (en) * 2009-05-13 2017-11-23 Basf Plant Science Company Gmbh Acyltransferases and uses thereof in fatty acid production
US9828589B2 (en) 2009-05-13 2017-11-28 Basf Plant Science Company Gmbh Acyltransferases and uses thereof in fatty acid production
WO2010130725A1 (en) * 2009-05-13 2010-11-18 Basf Plant Science Company Gmbh Acyltransferases and uses thereof in fatty acid production
AU2010247438B2 (en) * 2009-05-13 2015-01-29 Basf Plant Science Company Gmbh Acyltransferases and uses thereof in fatty acid production
US8524485B2 (en) 2009-06-16 2013-09-03 E I Du Pont De Nemours And Company Long chain omega-3 and omega-6 polyunsaturated fatty acid biosynthesis by expression of acyl-CoA lysophospholipid acyltransferases
WO2010147907A1 (en) 2009-06-16 2010-12-23 E. I. Du Pont De Nemours And Company High eicosapentaenoic acid oils from improved optimized strains of yarrowia lipolytica
US20100317882A1 (en) * 2009-06-16 2010-12-16 E. I. Du Pont De Nemours And Company LONG CHAIN OMEGA-3 AND OMEGA-6 POLYUNSATURATED FATTY ACID BIOSYNTHESIS BY EXPRESSION OF ACYL-CoA LYSOPHOSPHOLIPID ACYLTRANSFERASES
US9029122B2 (en) 2009-06-16 2015-05-12 E I Du Pont De Nemours And Company Long chain omega-3 and omega-6 polyunsaturated fatty acid biosynthesis by expression of acyl-CoA lysophospholipid acyltransferases
US20140161959A1 (en) * 2009-12-24 2014-06-12 E.I. Du Pont De Nemours And Company Plant Membrane O-Acyl Transferase (MBOAT) Family Protein Sequences and their Uses for Altering Fatty Acid Compositions
US9006514B2 (en) * 2009-12-24 2015-04-14 E. I. Du Pont De Nemours And Company Plant membrane O-acyl transferase (MBOAT) family protein sequences and their uses for altering fatty acid compositions
WO2013192002A1 (en) 2012-06-19 2013-12-27 E. I. Du Pont De Nemours And Company IMPROVED PRODUCTION OF POLYUNSATURATED FATTY ACIDS BY COEXPRESSION OF ACYL-CoA:LYSOPHOSPHATIDYLCHOLINE ACYLTRANSFERASES AND PHOSPHOLIPID:DIACYLGLYCEROL ACYLTRANSFERASES
JP2015519920A (en) * 2012-06-19 2015-07-16 イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニーE.I.Du Pont De Nemours And Company Improved production of polyunsaturated fatty acids by co-expression of acyl CoA: lysophosphatidylcholine acyltransferase and phospholipid: diacylglycerol acyltransferase
US9347075B2 (en) 2012-06-19 2016-05-24 E I Du Pont De Nemours And Company Nucleic acids encoding mutant acyl-CoA:lysophosphatidylcholine acyltransferases
US9416382B2 (en) 2012-06-19 2016-08-16 E I Du Pont De Nemours And Company Production of polyunsaturated fatty acids by coexpression of acyl-CoA:lysophosphatidylcholine acyltransferases and phospholipid:diacylglycerol acyltransferases
WO2013192007A1 (en) 2012-06-19 2013-12-27 E. I. Du Pont De Nemours And Company MUTANT ACYL-CoA:LYSOPHOSPHATIDYLCHOLINE ACYLTRANSFERASES
US9005940B2 (en) 2012-12-21 2015-04-14 E I Du Pont De Nemours And Company Down-regulation of a polynucleotide encoding a Sou2 sorbitol utilization protein to modify lipid production in microbial cells
US9441209B2 (en) 2012-12-21 2016-09-13 E I Du Pont De Nemours And Company Down-regulation of a polynucleotide encoding a Sou2 sorbitol utilization protein to modify lipid production in microbial cells
US9701989B2 (en) 2012-12-21 2017-07-11 E I Du Pont De Nemours And Company Recombinant microbial cells that produce at least 28% eicosapentaenoic acid as dry cell weight
WO2014100061A1 (en) 2012-12-21 2014-06-26 E. I. Du Pont De Nemours And Company Down-regulation of a polynucleotide encoding a sou2 sorbitol utilization protein to modify lipid production in microbial cells
CN113527464A (en) * 2021-07-19 2021-10-22 新景智源生物科技(苏州)有限公司 TCR recognizing MBOAT2

Also Published As

Publication number Publication date
US9228175B2 (en) 2016-01-05
US8383886B2 (en) 2013-02-26
US20130152230A1 (en) 2013-06-13
CA2671674A1 (en) 2008-06-26
WO2008076377A2 (en) 2008-06-26
US20100016431A1 (en) 2010-01-21
WO2008076377A3 (en) 2009-03-12
US7732155B2 (en) 2010-06-08
CA2862907C (en) 2020-08-25
AU2007334364A1 (en) 2008-06-26
CA2671674C (en) 2015-11-03
CA2862907A1 (en) 2008-06-26

Similar Documents

Publication Publication Date Title
US7732155B2 (en) Methods for identifying lysophosphatidylcholine acyltransferases
US11939614B2 (en) Genes and proteins for aromatic polyketide synthesis
EP2234474B1 (en) Diacylglycerol acyltransferase 2 genes and proteins encoded thereby from algae
Xu et al. Cloning and characterization of an acyl‐CoA‐dependent diacylglycerol acyltransferase 1 (DGAT1) gene from Tropaeolum majus, and a study of the functional motifs of the DGAT protein using site‐directed mutagenesis to modify enzyme activity and oil content
AU2012283708B2 (en) Genes and proteins for alkanoyl-CoA synthesis
US7939714B2 (en) Diacylglycerol acyltransferase nucleic acid sequences and associated products
US8124835B2 (en) Acyl-coa-dependent diacylglycerol acyltransferas 1 (DGAT1) gene from Tropaeolum majus, protein encoded thereby and uses thereof
AU2007334364B2 (en) Genes encoding a novel type of lysophophatidylcholine acyltransferases and their use to increase triacylglycerol production and/or modify fatty acid composition
CA2717940C (en) Algal glycerol-3-phosphate acyltransferase
US20060206960A1 (en) Higher plant cytosolic er-based glycerol-3-phosphate acyltransferase genes
ZHENG et al. Patent 2709067 Summary

Legal Events

Date Code Title Description
AS Assignment

Owner name: NATIONAL RESEARCH COUNCIL OF CANADA, CANADA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:ZOU, JITAO;CHEN, QILIN;XU, JINGYU;REEL/FRAME:023135/0729;SIGNING DATES FROM 20090710 TO 20090717

Owner name: DOW AGROSCIENCES LCC, INDIANA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:ZHENG, ZHIFU;REEL/FRAME:023135/0762

Effective date: 20090805

Owner name: NATIONAL RESEARCH COUNCIL OF CANADA,CANADA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:ZOU, JITAO;CHEN, QILIN;XU, JINGYU;SIGNING DATES FROM 20090710 TO 20090717;REEL/FRAME:023135/0729

Owner name: DOW AGROSCIENCES LCC,INDIANA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:ZHENG, ZHIFU;REEL/FRAME:023135/0762

Effective date: 20090805

Owner name: NATIONAL RESEARCH COUNCIL OF CANADA, CANADA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:ZOU, JITAO;CHEN, QILIN;XU, JINGYU;SIGNING DATES FROM 20090710 TO 20090717;REEL/FRAME:023135/0729

STCF Information on status: patent grant

Free format text: PATENTED CASE

FPAY Fee payment

Year of fee payment: 4

CC Certificate of correction
MAFP Maintenance fee payment

Free format text: PAYMENT OF MAINTENANCE FEE, 8TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1552)

Year of fee payment: 8

FEPP Fee payment procedure

Free format text: MAINTENANCE FEE REMINDER MAILED (ORIGINAL EVENT CODE: REM.); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

LAPS Lapse for failure to pay maintenance fees

Free format text: PATENT EXPIRED FOR FAILURE TO PAY MAINTENANCE FEES (ORIGINAL EVENT CODE: EXP.); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

STCH Information on status: patent discontinuation

Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362

FP Lapsed due to failure to pay maintenance fee

Effective date: 20220608

点击 这是indexloc提供的php浏览器服务,不要输入任何密码和下载